Antibiotic Dosage Chart
1. Amoxicillin
Generic name: Amoxicillin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute otitis media, sinusitis, susceptible respiratory infections | 500 mg every 8 hours or 875 mg every 12 hours, depending on indication. | 25–45 mg/kg/day divided every 12 hours; higher doses may be indicated for selected infections. |
2. Amoxicillin + Clavulanate
Generic name: Amoxicillin + Clavulanic acid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial sinusitis, bite wounds, selected respiratory and skin infections | 500/125 mg every 8 hours or 875/125 mg every 12 hours. | 25–45 mg/kg/day of the amoxicillin component divided every 12 hours; formulation-specific limits apply. |
3. Ampicillin
Generic name: Ampicillin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Susceptible enterococcal, respiratory, urinary and gastrointestinal infections | 250–500 mg orally every 6 hours; IV dosing depends on infection severity. | 50–200 mg/kg/day divided every 6 hours, depending on indication and age. |
4. Ampicillin + Sulbactam
Generic name: Ampicillin + Sulbactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Skin, intra-abdominal, gynecological and mixed bacterial infections | 1.5–3 g IV every 6 hours. | 200–300 mg/kg/day of the combined product divided every 6 hours; specialist guidance required. |
5. Penicillin V
Generic name: Phenoxymethylpenicillin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Streptococcal pharyngitis and susceptible streptococcal infections | 250–500 mg orally every 6–8 hours, depending on indication. | 25–50 mg/kg/day divided into 2–4 doses; maximum depends on indication. |
6. Penicillin G (Benzylpenicillin)
Generic name: Benzylpenicillin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Severe susceptible streptococcal and meningococcal infections | Dose varies widely; severe infections may require several million units IV every 4–6 hours. | Weight- and age-based dosing; neonatal and meningitis regimens require specialist protocols. |
7. Benzathine Penicillin G
Generic name: Benzathine benzylpenicillin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Syphilis and selected streptococcal disease prevention | 2.4 million units IM once for early syphilis; other stages require different schedules. | Syphilis treatment is weight- and stage-specific; use pediatric specialist guidance. |
8. Procaine Penicillin G
Generic name: Procaine benzylpenicillin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible infections where this formulation is indicated | Regimen depends on indication and product formulation; specialist-directed dosing. | Weight-based specialist dosing; no universal pediatric regimen. |
9. Flucloxacillin
Generic name: Flucloxacillin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| MSSA skin, soft-tissue and bone infections | 250–500 mg orally every 6 hours; severe infections require IV treatment. | 25–50 mg/kg/day orally divided into 4 doses; severe infection dosing differs. |
10. Dicloxacillin
Generic name: Dicloxacillin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| MSSA skin and soft-tissue infections | 250–500 mg orally every 6 hours. | 25–50 mg/kg/day divided every 6 hours; maximum dose depends on indication. |
11. Oxacillin
Generic name: Oxacillin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| MSSA bacteremia, endocarditis and serious infections | 1–2 g IV every 4–6 hours for serious infections. | 100–200 mg/kg/day IV divided every 4–6 hours; specialist dosing required. |
12. Nafcillin
Generic name: Nafcillin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Serious MSSA infections | 1–2 g IV every 4 hours for severe infections. | 100–200 mg/kg/day IV divided every 4–6 hours; specialist dosing required. |
13. Piperacillin
Generic name: Piperacillin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Serious susceptible gram-negative and mixed infections | 3–4 g IV every 4–6 hours, depending on indication. | Weight-based IV dosing under specialist protocol; maximum and interval vary. |
14. Piperacillin + Tazobactam
Generic name: Piperacillin + Tazobactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Hospital-acquired infections, complicated intra-abdominal and severe polymicrobial infections | 3.375–4.5 g IV every 6–8 hours; renal adjustment required. | 80–100 mg/kg/dose of the piperacillin component IV every 6–8 hours; specialist protocol required. |
15. Ticarcillin + Clavulanate
Generic name: Ticarcillin + Clavulanic acid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected serious susceptible gram-negative and mixed infections | Historically 3.1 g IV every 4–6 hours; availability varies by country. | Specialist-directed weight-based dosing; availability and protocols vary. |
16. Cephalexin
Generic name: Cephalexin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Skin, soft-tissue and susceptible urinary infections | 250–500 mg orally every 6 hours. | 25–50 mg/kg/day divided into 2–4 doses. |
17. Cefadroxil
Generic name: Cefadroxil
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Skin infections and susceptible urinary infections | 500 mg–1 g orally every 12–24 hours. | 30 mg/kg/day orally in 1–2 divided doses. |
18. Cefazolin
Generic name: Cefazolin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Surgical prophylaxis, MSSA and susceptible infections | 1–2 g IV every 8 hours; surgical prophylaxis commonly uses a single preoperative dose. | 25–100 mg/kg/day IV divided every 8 hours, according to indication. |
19. Cefaclor
Generic name: Cefaclor
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Otitis media, respiratory and susceptible skin infections | 250–500 mg orally every 8 hours. | 20–40 mg/kg/day divided every 8 hours. |
20. Cefuroxime
Generic name: Cefuroxime
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Respiratory, urinary, skin and soft-tissue infections | 250–500 mg orally every 12 hours; IV regimens differ. | 20–30 mg/kg/day orally divided every 12 hours; IV dosing differs. |
21. Cefprozil
Generic name: Cefprozil
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Pharyngitis, sinusitis and skin infections | 250–500 mg orally every 12–24 hours, depending on indication. | 7.5–15 mg/kg/dose every 12 hours; indication-specific maximum applies. |
22. Cefixime
Generic name: Cefixime
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected urinary and respiratory infections | 400 mg orally once daily or 200 mg every 12 hours. | 8 mg/kg/day orally once daily or divided every 12 hours; maximum 400 mg/day. |
23. Cefpodoxime
Generic name: Cefpodoxime proxetil
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Respiratory, urinary and skin infections | 100–200 mg orally every 12 hours, depending on infection. | 10 mg/kg/day divided every 12 hours; maximum depends on indication. |
24. Cefdinir
Generic name: Cefdinir
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Otitis media, sinusitis and selected respiratory infections | 300 mg every 12 hours or 600 mg once daily. | 14 mg/kg/day once daily or divided every 12 hours; maximum 600 mg/day. |
25. Cefotaxime
Generic name: Cefotaxime
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Meningitis, sepsis and serious susceptible infections | 1–2 g IV every 6–8 hours; meningitis regimens may require higher doses. | 100–200 mg/kg/day IV divided every 6–8 hours; neonatal schedules differ. |
26. Ceftriaxone
Generic name: Ceftriaxone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Pneumonia, meningitis, sepsis and selected urinary infections | 1–2 g IV/IM every 24 hours; meningitis commonly requires 2 g every 12 hours. | 50–100 mg/kg/day IV/IM; meningitis may require 100 mg/kg/day. Neonatal restrictions apply. |
27. Ceftazidime
Generic name: Ceftazidime
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Pseudomonas and other susceptible gram-negative infections | 1–2 g IV every 8 hours; renal adjustment required. | 100–150 mg/kg/day IV divided every 8 hours; age-specific maximum applies. |
28. Cefepime
Generic name: Cefepime
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Hospital-acquired pneumonia, febrile neutropenia and susceptible gram-negative infections | 1–2 g IV every 8–12 hours, depending on indication. | 50 mg/kg/dose IV every 8–12 hours; maximum adult dose applies. |
29. Cefixime + Clavulanate
Generic name: Cefixime + Clavulanic acid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Combination products marketed for selected respiratory or urinary infections | No universally established regimen; follow the specific approved product label and local guidance. | No standardized pediatric regimen; use only if specifically prescribed and label-supported. |
30. Cefoperazone
Generic name: Cefoperazone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Serious susceptible gram-negative and biliary infections | 1–2 g IV every 12 hours; regimen depends on severity and product guidance. | 50–200 mg/kg/day IV divided every 8–12 hours; specialist guidance required. |
31. Cefoperazone + Sulbactam
Generic name: Cefoperazone + Sulbactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected serious mixed and gram-negative infections | Common product regimens vary by ratio and local label; verify the amount of each component. | Specialist-directed weight-based dosing; product ratio and age affect regimen. |
32. Cefotetan
Generic name: Cefotetan
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Intra-abdominal, pelvic and surgical prophylaxis indications | 1–2 g IV every 12 hours; prophylaxis uses a different schedule. | Pediatric dosing is specialist-directed; confirm age-specific product guidance. |
33. Cefoxitin
Generic name: Cefoxitin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Intra-abdominal, pelvic and surgical prophylaxis indications | 1–2 g IV every 6–8 hours; prophylaxis schedule differs. | 80–160 mg/kg/day IV divided every 4–6 hours; specialist guidance required. |
34. Cefditoren
Generic name: Cefditoren pivoxil
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected community-acquired respiratory and skin infections | 200–400 mg orally every 12 hours with food, depending on indication. | Pediatric use is not established in many regions; check local product authorization. |
35. Cefpodoxime + Clavulanate
Generic name: Cefpodoxime proxetil + Clavulanic acid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Marketed combination for selected susceptible infections | No universal evidence-based combination dose; follow the exact approved product label. | No standardized pediatric regimen; specialist and product-label guidance required. |
36. Imipenem + Cilastatin
Generic name: Imipenem + Cilastatin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Severe polymicrobial, intra-abdominal and hospital-acquired infections | 500 mg IV every 6 hours; adjust for renal function and indication. | 15–25 mg/kg/dose IV every 6 hours; age restrictions and maximum dose apply. |
37. Meropenem
Generic name: Meropenem
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Meningitis, sepsis and serious resistant gram-negative infections | 1 g IV every 8 hours; meningitis commonly uses 2 g every 8 hours. | 20–40 mg/kg/dose IV every 8 hours, according to infection; maximum adult dose applies. |
38. Ertapenem
Generic name: Ertapenem
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated urinary, intra-abdominal and skin infections | 1 g IV/IM every 24 hours. | 15 mg/kg/dose every 12 hours for eligible children; maximum 1 g/day. |
39. Doripenem
Generic name: Doripenem
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected complicated urinary and intra-abdominal infections | 500 mg IV every 8 hours; use is restricted by local authorization and indication. | Pediatric safety and efficacy are not established for routine use. |
40. Biapenem
Generic name: Biapenem
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected serious susceptible bacterial infections in countries where approved | Dose depends on local product authorization and infection; specialist-directed. | No widely established routine pediatric regimen. |
41. Aztreonam
Generic name: Aztreonam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Susceptible aerobic gram-negative infections, including selected Pseudomonas infections | 1–2 g IV every 8–12 hours; severe infections may require more frequent dosing. | 30 mg/kg/dose IV every 6–8 hours in eligible children; specialist guidance required. |
42. Azithromycin
Generic name: Azithromycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected respiratory infections, pertussis and susceptible atypical infections | 500 mg on day 1, then 250 mg daily on days 2–5; other regimens depend on indication. | 10 mg/kg on day 1, then 5 mg/kg daily on days 2–5 for common 5-day regimen; indication-specific. |
43. Clarithromycin
Generic name: Clarithromycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Respiratory infections and selected combination regimens | 250–500 mg orally every 12 hours. | 7.5 mg/kg/dose orally every 12 hours; maximum 500 mg per dose. |
44. Erythromycin
Generic name: Erythromycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Pertussis and selected susceptible respiratory or skin infections | 250–500 mg orally every 6 hours; formulation and indication affect dose. | 30–50 mg/kg/day orally divided into 2–4 doses; age and indication matter. |
45. Roxithromycin
Generic name: Roxithromycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible respiratory and skin infections | 150 mg orally every 12 hours or 300 mg once daily where approved. | Weight-based dosing depends on national product guidance; not approved for all ages. |
46. Spiramycin
Generic name: Spiramycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected oral, dental and toxoplasmosis-related indications in certain settings | Dose varies by indication and national formulation; follow specialist protocol. | Weight-based specialist dosing; no single universal pediatric regimen. |
47. Josamycin
Generic name: Josamycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible respiratory and genital infections where available | Dose depends on local product label and infection. | Weight-based dosing according to local product label; specialist guidance advised. |
48. Doxycycline
Generic name: Doxycycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acne, tick-borne infections, chlamydia and selected respiratory infections | 100 mg orally or IV every 12 hours initially; regimen depends on infection. | For selected serious infections, 2.2 mg/kg/dose every 12 hours may be used under specialist guidance; age restrictions depend on indication. |
49. Tetracycline
Generic name: Tetracycline hydrochloride
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible infections and acne regimens | 250–500 mg orally every 6 hours, where indicated. | Generally avoided in children under 8 years; pediatric use requires specialist assessment. |
50. Minocycline
Generic name: Minocycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acne and selected susceptible bacterial infections | 200 mg initially, then 100 mg every 12 hours for some infections; acne regimens differ. | Generally avoided under 8 years; older pediatric use requires specialist and indication-specific guidance. |
51. Tigecycline
Generic name: Tigecycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated skin and intra-abdominal infections under approved indications | 100 mg IV loading dose, then 50 mg IV every 12 hours. | Not routine pediatric therapy; safety concerns and specialist-only use apply. |
52. Omadacycline
Generic name: Omadacycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Community-acquired bacterial pneumonia and acute bacterial skin infections in eligible adults | Loading and maintenance regimens depend on oral versus IV route; follow approved product label. | Safety and efficacy are not established for routine pediatric use. |
53. Sarecycline
Generic name: Sarecycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Inflammatory acne vulgaris | Weight-based oral dose once daily according to approved product label. | Approved for eligible patients aged 9 years and older; weight-based once-daily dosing. |
54. Gentamicin
Generic name: Gentamicin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Serious gram-negative infections and selected combination therapy | Dose based on body weight, renal function and drug-level monitoring; extended-interval regimens are common. | Age- and weight-based dosing with serum-level monitoring; neonatal dosing differs substantially. |
55. Amikacin
Generic name: Amikacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Serious susceptible gram-negative infections, including selected resistant infections | Commonly 15–20 mg/kg IV per day in divided or extended-interval dosing with monitoring. | Weight- and age-based dosing with therapeutic drug monitoring; neonatal schedules differ. |
56. Tobramycin
Generic name: Tobramycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Serious gram-negative infections and inhaled treatment in selected lung conditions | Systemic dosing is weight- and level-guided; inhaled regimens are product-specific. | Systemic dosing requires specialist monitoring; inhaled regimens depend on age and product approval. |
57. Streptomycin
Generic name: Streptomycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected tuberculosis and other specialist-directed infections | Weight-based IM dosing under the relevant disease-specific protocol. | Specialist-only weight-based dosing with renal, hearing and drug-level monitoring. |
58. Neomycin
Generic name: Neomycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected bowel decontamination and topical indications | Oral or topical dosing is indication- and formulation-specific; systemic use is generally avoided. | Not for routine systemic pediatric use; topical or oral use requires product-specific guidance. |
59. Ciprofloxacin
Generic name: Ciprofloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated urinary, gastrointestinal and selected gram-negative infections | 250–750 mg orally every 12 hours; IV regimens differ. | 10–20 mg/kg/dose orally every 12 hours for selected serious indications; specialist use only. |
60. Levofloxacin
Generic name: Levofloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Community-acquired pneumonia and selected urinary infections | 250–750 mg orally or IV every 24 hours, depending on infection. | Selected indications only; age- and weight-based dosing under specialist guidance. |
61. Moxifloxacin
Generic name: Moxifloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Community-acquired pneumonia and selected adult infections | 400 mg orally or IV every 24 hours. | Not routinely recommended in children; specialist-directed exceptional use only. |
62. Ofloxacin
Generic name: Ofloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected urinary, genital and susceptible bacterial infections | 200–400 mg orally every 12 hours, depending on indication. | Not routine first-line pediatric therapy; use only under specialist guidance. |
63. Norfloxacin
Generic name: Norfloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected urinary infections where still approved | 400 mg orally every 12 hours in labeled indications. | Not recommended for routine pediatric use. |
64. Gemifloxacin
Generic name: Gemifloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected community-acquired respiratory infections in adults | 320 mg orally once daily for the labeled duration. | Not established for routine pediatric use. |
65. Co-trimoxazole
Generic name: Trimethoprim + Sulfamethoxazole
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Urinary infections, susceptible skin infections and Pneumocystis treatment | Common UTI regimen: 160/800 mg orally every 12 hours; other indications require different dosing. | Dose by trimethoprim component; indication-specific weight-based dosing is required. |
66. Sulfadiazine
Generic name: Sulfadiazine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Toxoplasmosis combination therapy and selected susceptible infections | Toxoplasmosis regimens use divided doses with pyrimethamine and folinic acid under specialist supervision. | Specialist weight-based dosing; neonatal and age-related restrictions apply. |
67. Sulfisoxazole
Generic name: Sulfisoxazole
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible urinary infections where available | Dose is product- and indication-specific; check local labeling. | Weight-based dosing only under pediatric guidance; avoid in infants where contraindicated. |
68. Sulfadoxine + Pyrimethamine
Generic name: Sulfadoxine + Pyrimethamine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Malaria prevention or treatment only in specific national protocols | Use only where recommended by current malaria guidance; regimen depends on indication and resistance. | Weight-band dosing under current malaria guidelines; not suitable for all ages. |
69. Clindamycin
Generic name: Clindamycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Anaerobic, dental, skin and selected bone infections | 150–450 mg orally every 6 hours; IV dosing depends on severity. | 8–25 mg/kg/day orally divided into 3–4 doses; severe infection IV dosing differs. |
70. Lincomycin
Generic name: Lincomycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected serious susceptible gram-positive and anaerobic infections | 600 mg IM/IV every 8–12 hours; route and severity affect regimen. | 10–20 mg/kg/day IV divided into 2–3 doses; specialist guidance required. |
71. Vancomycin
Generic name: Vancomycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| MRSA and serious susceptible gram-positive infections; oral formulation for C. difficile | IV dose is weight- and AUC-guided; oral C. difficile regimens are different. | Weight- and age-based dosing with therapeutic monitoring; neonatal regimens differ. |
72. Teicoplanin
Generic name: Teicoplanin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Serious susceptible gram-positive infections | Loading doses followed by maintenance dosing; regimen depends on infection and renal function. | Age- and weight-based loading and maintenance dosing; specialist monitoring required. |
73. Dalbavancin
Generic name: Dalbavancin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute bacterial skin and skin-structure infections | 1,500 mg IV once or 1,000 mg IV followed by 500 mg one week later, according to regimen. | Pediatric dosing depends on age and weight; use approved specialist protocol. |
74. Oritavancin
Generic name: Oritavancin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute bacterial skin and skin-structure infections | 1,200 mg IV once over the approved infusion period. | Pediatric safety and efficacy are not established for routine use. |
75. Linezolid
Generic name: Linezolid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| MRSA, VRE and selected gram-positive infections | 600 mg orally or IV every 12 hours. | 10 mg/kg/dose every 8 hours for younger children; older children generally every 12 hours, subject to maximum dose. |
76. Tedizolid
Generic name: Tedizolid phosphate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute bacterial skin and skin-structure infections | 200 mg orally or IV once daily for 6 days. | Pediatric use depends on age and national approval; check current product labeling. |
77. Metronidazole
Generic name: Metronidazole
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Anaerobic infections, bacterial vaginosis and selected protozoal infections | 500 mg orally or IV every 8–12 hours for many indications; specific regimens vary. | 20–30 mg/kg/day divided every 6–8 hours for selected infections; indication-specific dosing required. |
78. Tinidazole
Generic name: Tinidazole
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Giardiasis, trichomoniasis and selected anaerobic or protozoal infections | Dose varies by indication; some regimens use a single 2 g oral dose. | Weight-based dosing for eligible children; age limits and maximum dose apply. |
79. Secnidazole
Generic name: Secnidazole
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial vaginosis and selected protozoal infections where approved | 2 g orally once for certain approved indications. | Pediatric approval and dosing vary by country and indication; verify local label. |
80. Nitrofurantoin
Generic name: Nitrofurantoin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Uncomplicated lower urinary tract infection | 100 mg orally every 12 hours for the monohydrate/macrocrystal formulation; other formulations differ. | 5–7 mg/kg/day divided every 6 hours for eligible children; avoid in young infants and unsuitable renal function. |
81. Furazolidone
Generic name: Furazolidone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Historical use for selected gastrointestinal infections; availability and recommendations vary | Not routinely recommended in many current guidelines; follow national guidance if used. | Not recommended for routine pediatric use without specialist direction. |
82. Rifampicin (Rifampin)
Generic name: Rifampicin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Tuberculosis combination therapy and selected prophylaxis indications | Tuberculosis dosing is weight-based and always part of a multidrug regimen. | Weight-based dosing under national TB or prophylaxis protocol; never use TB monotherapy. |
83. Rifabutin
Generic name: Rifabutin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Mycobacterial infections and selected TB regimens | 300 mg orally once daily in some adult regimens; interactions and indication affect dose. | Specialist weight-based dosing; pediatric experience is limited. |
84. Rifapentine
Generic name: Rifapentine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Latent tuberculosis infection and selected active TB combination regimens | Regimen-specific dosing, often weekly or daily as part of a defined multidrug protocol. | Age- and weight-band dosing under current TB guidance. |
85. Colistin
Generic name: Colistimethate sodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected multidrug-resistant gram-negative infections | Complex loading and maintenance dosing based on renal function and international units; specialist-only. | Specialist pediatric dosing with close renal and neurological monitoring. |
86. Polymyxin B
Generic name: Polymyxin B
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected multidrug-resistant gram-negative infections | Weight-based IV dosing under specialist protocol; toxicity monitoring required. | Specialist-only weight-based dosing; safety monitoring essential. |
87. Daptomycin
Generic name: Daptomycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| MRSA bacteremia, right-sided endocarditis and selected skin infections | 4–6 mg/kg IV every 24 hours for labeled indications; higher specialist doses may be used for selected infections. | Age- and weight-based IV dosing under specialist guidance; monitor creatine kinase. |
88. Quinupristin + Dalfopristin
Generic name: Quinupristin + Dalfopristin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected serious vancomycin-resistant gram-positive infections | 7.5 mg/kg IV every 8–12 hours for labeled indications. | Pediatric safety and efficacy are not established for routine use. |
89. Chloramphenicol
Generic name: Chloramphenicol
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected serious infections when safer alternatives are unsuitable | Specialist-directed dosing with blood-count monitoring; regimen depends on route and infection. | Avoid in neonates unless specialist protocol specifically indicates use; age-specific dosing and monitoring essential. |
90. Fosfomycin
Generic name: Fosfomycin tromethamine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Uncomplicated lower urinary tract infection | 3 g orally as a single dose for eligible adult women; other uses require different regimens. | Pediatric oral use is not routine; specialist and local-label guidance required. |
91. Nitrofurazone
Generic name: Nitrofurazone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Topical treatment of selected superficial wound infections where approved | Apply according to the specific topical product label. | Use only if approved for the child’s age and wound type; follow product label. |
92. Mupirocin
Generic name: Mupirocin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Localized impetigo and selected topical decolonization protocols | Apply 2% ointment to affected skin 3 times daily for up to 5 days, according to product label. | Topical use depends on age and product approval; follow pediatric label instructions. |
93. Retapamulin
Generic name: Retapamulin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Localized impetigo | Apply 1% ointment twice daily for 5 days to eligible affected areas. | Approved pediatric age range depends on country; apply according to product label. |
94. Fusidic Acid
Generic name: Fusidic acid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected staphylococcal skin infections; systemic use in certain countries | Topical application or systemic dosing depends on product and indication; follow local guidance. | Age- and formulation-specific dosing; specialist guidance for systemic treatment. |
95. Mafenide Acetate
Generic name: Mafenide acetate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Topical infection prevention and treatment in selected burn wounds | Apply according to burn-unit protocol and approved topical formulation. | Burn-specialist supervision required; use product-specific pediatric guidance. |
96. Silver Sulfadiazine
Generic name: Silver sulfadiazine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Topical infection prevention in selected burn wounds | Apply a thin layer to affected burn areas according to burn-care protocol. | Avoid in infants under 2 months; use in older children only under burn-specialist guidance. |
97. Lefamulin
Generic name: Lefamulin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Community-acquired bacterial pneumonia in eligible adults | 600 mg orally every 12 hours or 150 mg IV every 12 hours for 5 days. | Pediatric safety and efficacy are not established for routine use. |
98. Delafloxacin
Generic name: Delafloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute bacterial skin infections and selected adult respiratory infections where approved | 450 mg orally every 12 hours or 300 mg IV every 12 hours, depending on indication. | Not established for routine pediatric use. |
99. Eravacycline
Generic name: Eravacycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated intra-abdominal infections in eligible adults | 1 mg/kg IV every 12 hours. | Pediatric safety and efficacy are not established for routine use. |
100. Omadacycline
Generic name: Omadacycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Community-acquired bacterial pneumonia and acute bacterial skin infections in eligible adults | Oral or IV loading followed by 300 mg orally daily or 100 mg IV daily, depending on regimen. | Safety and efficacy are not established for routine pediatric use. |
101. Ceftaroline Fosamil
Generic name: Ceftaroline fosamil
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| MRSA skin infections and community-acquired bacterial pneumonia | 600 mg IV every 12 hours; duration depends on indication. | Age- and weight-based IV dosing: regimens range from 6–12 mg/kg every 8 hours in younger children to 400 mg every 8 hours or 600 mg every 12 hours in larger children; check label. |
102. Ceftolozane + Tazobactam
Generic name: Ceftolozane + Tazobactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated urinary and intra-abdominal infections; hospital-acquired pneumonia | 1.5 g IV every 8 hours for urinary/intra-abdominal infections; 3 g every 8 hours for hospital-acquired pneumonia. Adjust for renal function. | For eligible pediatric patients with selected indications: 30 mg/kg of the combined product IV every 8 hours, maximum 1.5 g per dose; specialist protocol required. |
103. Ceftazidime + Avibactam
Generic name: Ceftazidime + Avibactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated urinary, intra-abdominal and hospital-acquired respiratory infections | 2.5 g IV every 8 hours over 2 hours; renal adjustment required. | Age- and weight-based dosing using the ceftazidime and avibactam components; specialist dosing and renal assessment required. |
104. Cefepime + Enmetazobactam
Generic name: Cefepime + Enmetazobactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated urinary tract infections, including pyelonephritis | 2.5 g IV every 8 hours over 2 hours for the approved treatment course; renal adjustment required. | Routine pediatric dose is not established; use only according to local approval and specialist advice. |
105. Cefiderocol
Generic name: Cefiderocol
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Serious infections caused by susceptible multidrug-resistant gram-negative bacteria | 2 g IV every 8 hours over 3 hours for eligible adults with normal renal function; adjust for renal function. | Pediatric safety and efficacy are not established for routine use. |
106. Sulbactam + Durlobactam
Generic name: Sulbactam + Durlobactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Hospital-acquired and ventilator-associated pneumonia caused by susceptible Acinetobacter baumannii complex | 1 g/1 g IV every 6 hours over 3 hours, used with imipenem/cilastatin; renal adjustment required. | Pediatric safety and efficacy are not established for routine use. |
107. Imipenem + Cilastatin + Relebactam
Generic name: Imipenem + Cilastatin + Relebactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated urinary and intra-abdominal infections; hospital-acquired bacterial pneumonia in eligible adults | 1.25 g IV every 6 hours over 30 minutes; adjust for renal function. | Not established for routine pediatric use. |
108. Meropenem + Vaborbactam
Generic name: Meropenem + Vaborbactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated urinary tract infections caused by susceptible organisms, including selected resistant Enterobacterales | 4 g IV every 8 hours over 3 hours; renal adjustment required. | Pediatric safety and efficacy are not established for routine use. |
109. Cefepime + Tazobactam
Generic name: Cefepime + Tazobactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible gram-negative infections in countries where this combination is marketed | No universal regimen; follow the exact formulation’s approved local product information. | No standardized pediatric regimen; specialist and product-label guidance required. |
110. Ceftriaxone + Sulbactam
Generic name: Ceftriaxone + Sulbactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected bacterial infections where the combination is locally approved | Dose depends on the strength and ratio of the marketed product; verify both components. | Use only with a verified pediatric product regimen and specialist direction. |
111. Cloxacillin
Generic name: Cloxacillin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| MSSA skin, bone and bloodstream infections | 250–500 mg orally every 6 hours for selected mild infections; severe infections require IV regimens. | Weight-based dosing, commonly divided every 6 hours; dose depends on infection severity and route. |
112. Mecillinam
Generic name: Mecillinam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Susceptible urinary tract infections where available | Dose and route depend on the formulation; follow the national product label. | Pediatric regimen depends on formulation and local authorization; verify before use. |
113. Pivmecillinam
Generic name: Pivmecillinam hydrochloride
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Uncomplicated lower urinary tract infection | 400 mg orally three times daily for the locally recommended duration, where approved. | Pediatric use depends on age and national approval; use a pediatric formulary. |
114. Temocillin
Generic name: Temocillin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected serious infections caused by susceptible gram-negative bacteria | 2 g IV every 12 hours is used in some adult protocols; indication and renal function affect dosing. | Pediatric evidence and authorization are limited; specialist-directed dosing only. |
115. Carbenicillin
Generic name: Carbenicillin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Historical treatment of selected susceptible gram-negative infections | Availability is limited; use only a verified local formulation and specialist protocol. | No routine contemporary pediatric regimen; specialist guidance required. |
116. Ticarcillin
Generic name: Ticarcillin disodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Historical treatment of susceptible gram-negative and Pseudomonas infections | Use only where available and according to the local product label; renal adjustment required. | Specialist-directed weight-based dosing; availability is limited. |
117. Bacampicillin
Generic name: Bacampicillin hydrochloride
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Susceptible respiratory and urinary infections where marketed | Dose is product-specific; follow the local prescribing information. | Pediatric regimen varies by product and country; verify before use. |
118. Sultamicillin
Generic name: Sultamicillin (ampicillin + sulbactam prodrug)
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Susceptible respiratory, skin and soft-tissue infections | 375–750 mg orally every 12 hours, depending on indication and local product label. | Pediatric dosing is product-specific; confirm age, weight and approved formulation. |
119. Talampicillin
Generic name: Talampicillin hydrochloride
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Historical oral treatment of susceptible bacterial infections | Availability and approved dosing vary; consult the specific national product label. | No widely established current pediatric regimen. |
120. Sulbenicillin
Generic name: Sulbenicillin sodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible gram-negative infections in countries where available | Use the country-specific injectable product label and specialist protocol. | No universal pediatric regimen; specialist dosing required. |
121. Isoniazid
Generic name: Isoniazid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Tuberculosis treatment and latent TB infection regimens | Common daily adult dose: 5 mg/kg, maximum 300 mg; always follow a TB regimen. | Common daily dose: 10–15 mg/kg, maximum 300 mg; regimen and duration depend on TB guidance. |
122. Pyrazinamide
Generic name: Pyrazinamide
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Active tuberculosis as part of multidrug therapy | Weight-based daily dose, commonly 20–25 mg/kg, according to national TB protocol. | Weight-based daily dose, commonly 30–40 mg/kg under pediatric TB guidance. |
123. Ethambutol
Generic name: Ethambutol hydrochloride
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Active tuberculosis as part of combination therapy | 15–20 mg/kg orally once daily, adjusted to the TB regimen. | 15–25 mg/kg orally once daily under pediatric TB specialist guidance; monitor vision where feasible. |
124. Bedaquiline
Generic name: Bedaquiline fumarate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Drug-resistant tuberculosis as part of an approved multidrug regimen | 400 mg daily for 2 weeks, then 200 mg three times weekly for 22 weeks in the standard adult schedule. | Age- and weight-band dosing under specialist drug-resistant TB protocols; ECG and interaction monitoring required. |
125. Delamanid
Generic name: Delamanid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Multidrug-resistant tuberculosis in combination regimens | 100 mg orally twice daily for the approved treatment period, according to TB protocol. | Weight-band dosing for eligible children under specialist TB guidance; ECG monitoring required. |
126. Pretomanid
Generic name: Pretomanid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected drug-resistant tuberculosis combination regimens | 200 mg orally once daily with food as part of a specialist multidrug regimen. | Pediatric safety and efficacy are not established for routine use. |
127. Clofazimine
Generic name: Clofazimine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Leprosy and selected drug-resistant tuberculosis regimens | Leprosy regimens commonly use 50 mg daily plus supervised monthly dosing; TB regimens differ. | Weight-based multidrug leprosy or TB regimen under specialist supervision. |
128. Cycloserine
Generic name: Cycloserine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Drug-resistant tuberculosis combination therapy | Usually 500–750 mg daily in divided doses; maximum and schedule depend on monitoring and TB protocol. | Weight-based dosing with specialist monitoring for neurological and psychiatric adverse effects. |
129. Ethionamide
Generic name: Ethionamide
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Drug-resistant tuberculosis as part of combination therapy | 15–20 mg/kg/day orally, usually divided; maximum 1 g/day in many protocols. | 15–20 mg/kg/day orally under specialist TB guidance; maximum depends on protocol. |
130. Para-Aminosalicylic Acid (PAS)
Generic name: Para-aminosalicylic acid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Drug-resistant tuberculosis as part of a multidrug regimen | 8–12 g daily orally in divided doses, depending on formulation and tolerance. | Weight-based dosing under specialist TB guidance; formulation-specific maximum applies. |
131. Dapsone
Generic name: Dapsone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Leprosy combination therapy and selected Pneumocystis prevention regimens | Dose varies by indication; leprosy regimens commonly use 100 mg daily with other medicines. | Weight-based specialist dosing; check G6PD status and monitor for hemolysis and methemoglobinemia. |
132. Minocycline for Leprosy Combination Therapy
Generic name: Minocycline hydrochloride
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected alternative multidrug regimens for leprosy | 100 mg orally daily in selected specialist protocols. | Not routine in younger children; specialist leprosy protocol required. |
133. Ofloxacin for Leprosy Combination Therapy
Generic name: Ofloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected alternative multidrug regimens for leprosy | 400 mg orally daily in selected specialist protocols. | Not routine pediatric therapy; specialist and national leprosy guidance required. |
134. Rifapentine + Isoniazid
Generic name: Rifapentine + Isoniazid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Latent tuberculosis infection in eligible patients | Once-weekly combination for 3 months using weight-based rifapentine and isoniazid doses under TB guidance. | Weight-band dosing for eligible children; confirm age, weight and national TB protocol. |
135. Rifampicin + Isoniazid
Generic name: Rifampicin + Isoniazid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Tuberculosis continuation-phase combination therapy | Fixed-dose combination selected by weight under the national TB programme. | Pediatric fixed-dose combination selected by weight band under national TB guidance. |
136. Rifampicin + Isoniazid + Pyrazinamide
Generic name: Rifampicin + Isoniazid + Pyrazinamide
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Initial-phase tuberculosis combination therapy | Use the fixed-dose combination strength and tablet count selected by body weight under TB protocol. | Use pediatric fixed-dose combinations and weight bands; do not calculate from adult tablets. |
137. Rifampicin + Isoniazid + Pyrazinamide + Ethambutol
Generic name: Rifampicin + Isoniazid + Pyrazinamide + Ethambutol
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Initial-phase tuberculosis treatment using fixed-dose combination | Select tablet count by body weight and national TB programme guidance. | Use approved pediatric fixed-dose combinations according to weight band and TB protocol. |
138. Rifampicin + Ethambutol
Generic name: Rifampicin + Ethambutol
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected continuation or specialist-directed mycobacterial regimens | Dose each component according to the specific mycobacterial treatment protocol. | Weight-based specialist regimen; fixed-dose product strength must be checked. |
139. Rifampicin + Isoniazid + Ethambutol
Generic name: Rifampicin + Isoniazid + Ethambutol
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected tuberculosis regimens | Fixed-dose combination selected by body weight and national TB protocol. | Pediatric weight-band dosing under TB specialist guidance. |
140. Amikacin for Drug-Resistant Tuberculosis
Generic name: Amikacin sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected drug-resistant tuberculosis regimens when susceptibility and guidelines support use | Weight-based intermittent dosing under specialist TB protocol with audiology, renal and drug-level monitoring. | Specialist weight-based dosing and intensive monitoring; not a routine first-line pediatric TB medicine. |
141. Besifloxacin
Generic name: Besifloxacin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | One drop in the affected eye(s) three times daily for 7 days, according to product label. | Use in eligible children according to the approved age range and product label. |
142. Gatifloxacin Ophthalmic
Generic name: Gatifloxacin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | One drop in the affected eye(s); frequency varies by concentration and product schedule. | Use product-specific pediatric instructions; age authorization varies by formulation. |
143. Levofloxacin Ophthalmic
Generic name: Levofloxacin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis and susceptible superficial eye infections | One to two drops in the affected eye(s) at product-specific intervals. | Use the formulation-specific schedule and approved pediatric age range. |
144. Moxifloxacin Ophthalmic
Generic name: Moxifloxacin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | One drop in the affected eye(s) three times daily for 7 days for commonly used 0.5% products. | Use the approved product schedule for the child’s age. |
145. Ciprofloxacin Ophthalmic
Generic name: Ciprofloxacin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis and corneal ulcer treatment | Conjunctivitis: one to two drops every 2 hours initially while awake, then reduce frequency; corneal ulcer dosing is more intensive. | Age- and diagnosis-specific ophthalmic schedule; corneal ulcer requires ophthalmologist supervision. |
146. Ofloxacin Ophthalmic
Generic name: Ofloxacin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis and corneal ulcer | Conjunctivitis: one to two drops every 2–4 hours initially, then reduce according to label. | Use only the age- and indication-specific ophthalmic schedule. |
147. Tobramycin Ophthalmic
Generic name: Tobramycin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis and susceptible eye infections | One to two drops every 4 hours for mild-to-moderate infection; severe infections need a different schedule. | Use the ophthalmic product label and age-specific instructions. |
148. Gentamicin Ophthalmic
Generic name: Gentamicin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Susceptible bacterial conjunctivitis and superficial eye infections | One to two drops every 4 hours; severe infection requires specialist-directed frequency. | Follow age-specific ophthalmic labeling and clinician instructions. |
149. Erythromycin Ophthalmic
Generic name: Erythromycin ophthalmic ointment
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis and neonatal ophthalmia prophylaxis where indicated | Apply a ribbon of ointment to the affected eye(s) up to 6 times daily, depending on indication. | Treatment is product- and diagnosis-specific; neonatal prophylaxis follows local newborn protocol. |
150. Azithromycin Ophthalmic
Generic name: Azithromycin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | One drop twice daily for 2 days, then once daily for 5 days for the labeled 1% product. | Pediatric age approval varies; follow the exact product label. |
151. Chloramphenicol Ophthalmic
Generic name: Chloramphenicol eye drops or ointment
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis where locally approved | Drops or ointment at product-specific intervals for the recommended course. | Age restrictions and schedules vary by country; avoid unsupervised use in infants. |
152. Sulfacetamide Ophthalmic
Generic name: Sulfacetamide sodium ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Susceptible bacterial conjunctivitis | One to two drops in the affected eye(s) at label-specific intervals. | Use only in age groups permitted by the product label; avoid in infants unless specifically directed. |
153. Bacitracin Ophthalmic
Generic name: Bacitracin ophthalmic ointment
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Superficial bacterial eye infections caused by susceptible organisms | Apply a thin ribbon to the affected eye(s) according to product label. | Use under clinician direction and according to the approved pediatric product label. |
154. Polymyxin B + Trimethoprim Ophthalmic
Generic name: Polymyxin B + Trimethoprim ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | One drop every 3 hours, up to 6 doses daily, for the labeled course. | Use according to the approved age range and product label. |
155. Neomycin + Polymyxin B + Bacitracin Ophthalmic
Generic name: Neomycin + Polymyxin B + Bacitracin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Superficial susceptible bacterial eye infections | Apply ointment to the affected eye(s) according to product label. | Use only with pediatric clinician guidance and label confirmation. |
156. Neomycin + Polymyxin B + Dexamethasone Ophthalmic
Generic name: Neomycin + Polymyxin B + Dexamethasone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected steroid-responsive inflammatory eye conditions with bacterial infection or risk | Product-specific drops or ointment only after ophthalmic assessment. | Specialist ophthalmologist only; steroid-containing eye medicines can worsen some infections. |
157. Tobramycin + Dexamethasone Ophthalmic
Generic name: Tobramycin + Dexamethasone ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Steroid-responsive eye inflammation with bacterial infection or risk | Use the prescribed ophthalmic schedule following eye examination. | Specialist-directed only; age approval and monitoring are product-specific. |
158. Gramicidin + Neomycin + Polymyxin B Ophthalmic
Generic name: Gramicidin + Neomycin + Polymyxin B
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected superficial bacterial eye infections | Use drops or ointment according to the exact combination product label. | Pediatric use depends on local authorization and formulation. |
159. Oxytetracycline Ophthalmic
Generic name: Oxytetracycline ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected superficial bacterial eye infections where available | Apply ophthalmic ointment according to the specific product label. | Age restrictions and product availability vary; clinician guidance required. |
160. Framycetin Ophthalmic
Generic name: Framycetin sulfate ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible superficial bacterial eye infections | Use the ophthalmic drops or ointment according to product-specific instructions. | Follow local pediatric product labeling; specialist advice is recommended. |
161. Bacitracin Topical
Generic name: Bacitracin topical
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Minor superficial skin wounds at risk of localized infection | Apply a thin layer to the affected area 1–3 times daily according to product label. | Use a thin topical layer only when appropriate for the child’s age and wound; avoid extensive application. |
162. Polymyxin B Topical
Generic name: Polymyxin B sulfate topical
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Minor superficial wounds involving susceptible organisms | Apply according to the topical product label, generally as a thin layer. | Use only on suitable small areas and according to pediatric product directions. |
163. Neomycin Topical
Generic name: Neomycin sulfate topical
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Minor superficial skin wounds where topical antibiotic use is appropriate | Apply a thin layer according to product label; avoid prolonged or extensive use. | Use only when appropriate for age and wound size; monitor for contact allergy. |
164. Retapamulin Topical
Generic name: Retapamulin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Localized impetigo | Apply 1% ointment twice daily for 5 days, according to product label. | Use only in the approved age range; follow the same product-specific application schedule. |
165. Ozenoxacin
Generic name: Ozenoxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Impetigo caused by susceptible Staphylococcus aureus or Streptococcus pyogenes | Apply 1% cream to affected skin twice daily for 5 days. | Use in eligible children according to the approved age range and product label. |
166. Retapamulin + Other Topical Combination Products
Generic name: Retapamulin-containing topical combination
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| No routine combination indication established | No standard combination regimen; do not infer dosing from single-agent products. | Not established; verify that a locally approved combination exists before use. |
167. Ozenoxacin Topical Cream
Generic name: Ozenoxacin 1% cream
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Localized impetigo | Apply to affected area twice daily for 5 days. | Use only in approved pediatric age groups and on the labeled body area. |
168. Mupirocin Nasal
Generic name: Mupirocin calcium nasal ointment
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Nasal carriage decolonization of Staphylococcus aureus, including MRSA protocols | Apply a small amount inside each nostril twice daily for 5 days, where prescribed. | Pediatric use depends on age and product approval; follow infection-control protocol. |
169. Bacitracin + Neomycin + Polymyxin B Topical
Generic name: Bacitracin + Neomycin + Polymyxin B
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Minor superficial cuts and abrasions | Apply a thin layer according to the product label; not for deep or extensive wounds. | Use only for suitable minor wounds and according to the pediatric product label. |
170. Fusidic Acid + Hydrocortisone
Generic name: Fusidic acid + Hydrocortisone acetate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected infected eczematous skin conditions where combination therapy is indicated | Apply a thin layer for the shortest prescribed course; avoid prolonged steroid use. | Use only under clinician supervision; age, site and steroid strength affect suitability. |
171. Fusidic Acid + Betamethasone
Generic name: Fusidic acid + Betamethasone valerate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected infected inflammatory skin conditions | Apply sparingly for a short prescribed course; avoid large areas and prolonged use. | Pediatric use requires clinician assessment of age, skin site and steroid potency. |
172. Clindamycin Topical
Generic name: Clindamycin phosphate topical
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Inflammatory acne vulgaris | Apply 1% gel, lotion or solution once or twice daily according to product label; combine with appropriate acne stewardship therapy. | Use in eligible adolescents according to age-specific product labeling. |
173. Erythromycin Topical
Generic name: Erythromycin topical
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acne vulgaris | Apply the prescribed topical formulation once or twice daily; avoid antibiotic monotherapy where resistance is a concern. | Use in eligible adolescents according to local product labeling. |
174. Nadifloxacin
Generic name: Nadifloxacin topical
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acne and selected superficial bacterial skin infections where approved | Apply 1% cream or gel according to local product directions. | Pediatric approval varies; do not use without age-specific product guidance. |
175. Ozenoxacin Topical (Impetigo)
Generic name: Ozenoxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Localized non-bullous impetigo | Apply twice daily for 5 days as directed by the product label. | Same labeled topical schedule for eligible pediatric age groups. |
176. Metronidazole Topical
Generic name: Metronidazole topical
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Rosacea-associated inflammatory lesions; not a substitute for systemic treatment of deep infection | Apply the prescribed topical strength once or twice daily according to product label. | Routine pediatric use is not established; specialist guidance required. |
177. Clioquinol Topical
Generic name: Clioquinol topical
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected superficial skin infections where approved | Apply according to the exact topical product label for a short course. | Age and body-area restrictions vary; use only with clinician advice. |
178. Sulfadiazine Silver Topical
Generic name: Silver sulfadiazine topical
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Prevention and treatment of infection in selected burn wounds | Apply a thin layer to affected burn areas according to burn-care protocol. | Avoid in infants under 2 months; specialist burn-care direction required for older children. |
179. Mafenide Acetate Topical
Generic name: Mafenide acetate topical
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Burn wound infection prevention and treatment in selected cases | Apply cream or solution according to burn-unit protocol and formulation. | Burn-specialist supervision required; dosing depends on formulation and burn area. |
180. Neomycin + Bacitracin Topical
Generic name: Neomycin + Bacitracin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Minor superficial wounds where topical antibiotic use is appropriate | Apply a thin layer according to the product label; stop if irritation or allergy occurs. | Use only for small suitable areas and according to pediatric label instructions. |
181. Spectinomycin
Generic name: Spectinomycin hydrochloride
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected gonorrhea treatment where available and recommended by local guidance | Historically 2 g IM once; current use depends on resistance patterns and national guidance. | No routine pediatric regimen; specialist and current STI guidance required. |
182. Pristinamycin
Generic name: Pristinamycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected gram-positive infections in countries where approved | Dose depends on the indication and local formulation; use national product information. | Pediatric dosing is country- and age-specific; specialist guidance required. |
183. Rifaximin
Generic name: Rifaximin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected non-invasive diarrheal illness, hepatic encephalopathy prevention and other approved intestinal indications | 200 mg three times daily for 3 days for eligible traveler’s diarrhea; other indications use different schedules. | Routine pediatric safety and efficacy are not established for many indications; check local approval. |
184. Rifaximin + Other Gut-Directed Regimens
Generic name: Rifaximin (single-agent intestinal formulation)
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Indication-specific intestinal infections or hepatic encephalopathy prevention | Use the approved indication-specific regimen; do not combine or extend treatment without review. | Not routinely established for children; specialist guidance required. |
185. Bacitracin (Systemic Formulation)
Generic name: Bacitracin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Historical specialist use for selected serious gram-positive infections | Systemic bacitracin is not routine due to nephrotoxicity; no general regimen recommended. | Not recommended for routine systemic pediatric use. |
186. Paromomycin
Generic name: Paromomycin sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Intestinal amoebiasis and selected specialist-directed parasitic infections | 25–35 mg/kg/day orally divided into 3 doses for the labeled course in intestinal amoebiasis. | Weight-based dosing under pediatric infectious-disease guidance; indication-specific regimen required. |
187. Rolitetracycline
Generic name: Rolitetracycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Historical treatment of susceptible infections where available | Use only where licensed and according to the specific injectable product label. | Not routine pediatric therapy; tetracycline-class age restrictions apply. |
188. Lymecycline
Generic name: Lymecycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acne vulgaris and selected susceptible infections where approved | 300 mg orally once daily for acne in commonly used adult regimens. | Generally avoid in children under 8 years; older pediatric use depends on local authorization. |
189. Oxytetracycline Systemic
Generic name: Oxytetracycline hydrochloride
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible infections where still approved | Dose depends on indication and local product label; use is limited in many settings. | Generally avoid in children under 8 years; specialist guidance required for exceptions. |
190. Chlortetracycline Topical
Generic name: Chlortetracycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected topical or ophthalmic susceptible infections where available | Use the specific topical or ophthalmic formulation according to its label. | Age and route restrictions vary; use only with product-specific pediatric guidance. |
191. Demeclocycline
Generic name: Demeclocycline hydrochloride
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Historical treatment of selected susceptible infections; other specialist uses exist | Not commonly selected for routine bacterial infection; follow a verified indication-specific protocol. | Avoid in children under 8 years; not a routine pediatric antibiotic. |
192. Omadacycline Oral
Generic name: Omadacycline tosylate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Community-acquired bacterial pneumonia and acute bacterial skin infections in eligible adults | Oral loading regimen followed by 300 mg orally once daily; take according to food and mineral restrictions in the label. | Not established for routine pediatric use. |
193. Eravacycline IV
Generic name: Eravacycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated intra-abdominal infections in adults | 1 mg/kg IV every 12 hours; adjust only according to approved product guidance. | Not indicated for routine pediatric use. |
194. Lefamulin IV
Generic name: Lefamulin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Community-acquired bacterial pneumonia in eligible adults | 150 mg IV every 12 hours over 1 hour for 5–7 days, according to product label. | Pediatric safety and efficacy are not established for routine use. |
195. Delafloxacin IV
Generic name: Delafloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute bacterial skin and skin-structure infections; selected adult pneumonia indications where approved | 300 mg IV every 12 hours for the approved course; adjust for severe renal impairment as directed. | Not established for routine pediatric use. |
196. Ertapenem for Pediatric Infections
Generic name: Ertapenem sodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated intra-abdominal, urinary and skin infections caused by susceptible organisms | 1 g IV or IM once daily for eligible adults. | 15 mg/kg IV/IM every 12 hours for children aged 3 months to 12 years; maximum 1 g/day. Age restrictions apply. |
197. Cefazolin for Surgical Prophylaxis
Generic name: Cefazolin sodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Perioperative prevention of susceptible surgical-site infections | 2 g IV within 60 minutes before incision; 3 g for adults weighing 120 kg or more; redosing depends on procedure. | 30 mg/kg IV before incision, maximum 2 g in common protocols; institutional surgical guidance applies. |
198. Cefuroxime for Surgical Prophylaxis
Generic name: Cefuroxime sodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Perioperative prophylaxis for selected surgical procedures | 1.5 g IV before incision in common adult protocols; redosing depends on procedure and duration. | Weight-based preoperative dose under the pediatric surgical prophylaxis protocol. |
199. Cefotaxime for Neonatal Infection
Generic name: Cefotaxime sodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Neonatal sepsis and meningitis caused by susceptible organisms | Adult dosing is not applicable to neonatal infection; adult regimens depend on indication. | Dose and interval depend on gestational age, postnatal age, weight and meningitis status; use a neonatal formulary. |
200. Benzylpenicillin for Neonatal Infection
Generic name: Benzylpenicillin sodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Neonatal sepsis, meningitis and susceptible streptococcal infections | Adult regimens vary substantially by infection and severity; not interchangeable with neonatal dosing. | Use gestational-age- and postnatal-age-specific neonatal dosing; meningitis requires a separate protocol. |
201. Ceftaroline Fosamil
Generic name: Ceftaroline fosamil
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Skin infections; community-acquired pneumonia | 600 mg IV every 12 hours; adjust for renal function. | Age- and weight-based IV dosing; specialist/label guidance required. |
202. Ceftolozane/Tazobactam
Generic name: Ceftolozane + tazobactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated urinary or intra-abdominal infections; hospital-acquired pneumonia | 1.5 g IV every 8 hours for cUTI/cIAI; 3 g IV every 8 hours for HABP/VABP. Use metronidazole for cIAI. | Selected cIAI/cUTI: 30 mg/kg IV every 8 hours (maximum 1.5 g per dose); specialist guidance required. |
203. Ceftazidime/Avibactam
Generic name: Ceftazidime + avibactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated urinary and intra-abdominal infections; selected resistant Gram-negative infections | 2.5 g IV every 8 hours over 2 hours when renal function permits; adjust for renal impairment. | Age- and weight-based dosing under specialist supervision; renal adjustment required. |
204. Cefiderocol
Generic name: Cefiderocol
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated urinary infections; selected resistant Gram-negative infections | 2 g IV every 8 hours over 3 hours for adults with normal renal function; adjust for renal function. | Not established; specialist-directed use only. |
205. Meropenem/Vaborbactam
Generic name: Meropenem + vaborbactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated urinary infections caused by susceptible resistant bacteria | 4 g IV every 8 hours over 3 hours; adjust for renal function. | Not established; specialist-directed use only. |
206. Imipenem/Cilastatin/Relebactam
Generic name: Imipenem + cilastatin + relebactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated urinary infections; hospital-acquired bacterial pneumonia | 1.25 g IV every 6 hours; adjust for renal function. | Not established; specialist-directed use only. |
207. Sulbactam/Durlobactam
Generic name: Sulbactam + durlobactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Hospital-acquired and ventilator-associated bacterial pneumonia caused by susceptible Acinetobacter | 1 g/1 g IV every 6 hours over 3 hours, with imipenem/cilastatin; adjust for renal function. | Not established; specialist-directed use only. |
208. Eravacycline
Generic name: Eravacycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated intra-abdominal infections | 1 mg/kg IV every 12 hours. | Not established; avoid routine use in children. |
209. Omadacycline
Generic name: Omadacycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Community-acquired bacterial pneumonia; acute bacterial skin infections | Loading dose 200 mg IV once or 100 mg IV twice on day 1, then 100 mg IV daily; oral regimen differs. | Not established; specialist-directed use only. |
210. Lefamulin
Generic name: Lefamulin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Community-acquired bacterial pneumonia | 150 mg IV every 12 hours or 600 mg orally every 12 hours; treatment duration and route depend on clinical response. | Not established; specialist-directed use only. |
211. Delafloxacin
Generic name: Delafloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute bacterial skin infections; community-acquired pneumonia | 300 mg IV every 12 hours or 450 mg orally every 12 hours. | Not established; avoid routine use in children. |
212. Plazomicin
Generic name: Plazomicin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated urinary tract infections | 15 mg/kg IV every 24 hours; adjust using renal function and drug-level monitoring. | Not established; specialist-directed use only. |
213. Pivmecillinam
Generic name: Pivmecillinam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Uncomplicated urinary tract infection | 400 mg orally three times daily for the locally recommended course, where licensed. | Use only where approved; age- and weight-specific local guidance required. |
214. Temocillin
Generic name: Temocillin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated urinary infections; selected Gram-negative infections | 2 g IV every 12 hours; severe infections may require a different specialist regimen. | Specialist-directed, weight-based dosing; local guidance required. |
215. Fosfomycin (Intravenous)
Generic name: Fosfomycin disodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Severe infections caused by susceptible bacteria | Dose varies widely by infection and country-specific product; specialist-directed IV regimen required. | Specialist-directed, weight-based dosing only. |
216. Colistimethate Sodium
Generic name: Colistimethate sodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Serious infections caused by susceptible multidrug-resistant Gram-negative bacteria | Individualized loading and maintenance dosing based on renal function and product units; infectious-disease specialist required. | Individualized specialist dosing; do not extrapolate adult dosing. |
217. Polymyxin B
Generic name: Polymyxin B
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected serious multidrug-resistant Gram-negative infections | Specialist-directed IV dosing based on body weight and clinical circumstances; monitor for toxicity. | Specialist-directed dosing only; not suitable for routine extrapolation. |
218. Streptomycin
Generic name: Streptomycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected tuberculosis and other specialist-managed infections | Regimen depends on indication; use specialist protocol with renal, hearing and drug-level monitoring. | Weight-based specialist regimen only. |
219. Capreomycin
Generic name: Capreomycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Drug-resistant tuberculosis, where included in a specialist regimen | Use current national TB program and specialist regimen; availability and recommendations vary. | Specialist TB-team dosing only. |
220. Clofazimine
Generic name: Clofazimine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Leprosy; selected drug-resistant tuberculosis regimens | Use the indication-specific multidrug regimen; do not use as monotherapy. | Weight-based specialist regimen; national leprosy/TB guidance required. |
221. Cycloserine
Generic name: Cycloserine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Drug-resistant tuberculosis | Specialist-directed divided oral dosing with serum-level and neuropsychiatric monitoring. | Weight-based specialist TB regimen only. |
222. Ethionamide
Generic name: Ethionamide
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Drug-resistant tuberculosis | Specialist-directed oral dosing as part of a multidrug regimen; monitor liver function and tolerance. | Weight-based specialist TB regimen only. |
223. Para-Aminosalicylic Acid (PAS)
Generic name: Para-aminosalicylic acid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Drug-resistant tuberculosis | Specialist-directed oral regimen according to formulation and national TB protocol. | Weight-based specialist TB regimen only. |
224. Bedaquiline
Generic name: Bedaquiline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Drug-resistant tuberculosis | Use the approved loading and continuation schedule as part of a multidrug TB regimen; monitor QT interval and liver function. | Age- and weight-specific specialist TB protocol required. |
225. Delamanid
Generic name: Delamanid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Drug-resistant tuberculosis | Use current approved multidrug TB regimen; monitor ECG and QT interval. | Age- and weight-specific specialist TB protocol required. |
226. Pretomanid
Generic name: Pretomanid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected drug-resistant tuberculosis regimens | 200 mg orally once daily as part of the specified combination regimen; never use alone. | Not established for routine pediatric use; specialist TB team required. |
227. Rifabutin
Generic name: Rifabutin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Tuberculosis; Mycobacterium avium complex prevention or treatment | Common adult dose is 300 mg orally daily; interactions and indication-specific regimens require review. | Weight-based specialist dosing; check interactions and local protocol. |
228. Rifapentine
Generic name: Rifapentine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Latent tuberculosis; selected active TB regimens | Schedule depends on the TB regimen; use current national TB guidance. | Weight-based regimen under TB specialist supervision. |
229. Isoniazid/Rifapentine
Generic name: Isoniazid + rifapentine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Latent tuberculosis infection | Once-weekly combination regimen for 3 months where indicated; dose by formulation and guideline. | Weight-based once-weekly regimen under TB program guidance. |
230. Isoniazid/Rifampicin/Pyrazinamide/Ethambutol
Generic name: HRZE fixed-dose combination
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Drug-susceptible active tuberculosis | Use weight-band fixed-dose combination according to national TB program during the intensive phase. | Pediatric weight-band formulation and TB-program schedule required. |
231. Mupirocin
Generic name: Mupirocin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Localized impetigo; selected skin infections | Apply 2% ointment to affected skin three times daily for up to 5 days, according to product labeling. | Use only for approved ages and indications; apply as directed by the product label. |
232. Retapamulin
Generic name: Retapamulin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Localized impetigo | Apply 1% ointment to affected area twice daily for 5 days, where licensed. | Use only in age groups approved by the local product label. |
233. Ozenoxacin
Generic name: Ozenoxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Impetigo | Apply 1% cream to affected area twice daily for 5 days, according to labeling. | Age approval varies by country; follow local label and prescriber instructions. |
234. Fusidic Acid (Topical)
Generic name: Fusidic acid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Localized bacterial skin infections | Apply 2% cream or ointment according to local product labeling, generally 2–3 times daily for a short course. | Use age-appropriate topical product and local label instructions. |
235. Silver Sulfadiazine
Generic name: Silver sulfadiazine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Prevention and treatment of infection in burns | Apply 1% cream to the burn wound as directed, usually once or twice daily after wound cleansing. | Avoid in premature infants and newborns; pediatric burn specialist guidance required. |
236. Mafenide Acetate
Generic name: Mafenide acetate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Burn wound infection prevention and treatment | Apply topical cream or solution according to burn-unit protocol and product labeling. | Specialist pediatric burn-unit dosing only. |
237. Bacitracin (Topical)
Generic name: Bacitracin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Minor superficial skin wounds | Apply a thin layer to the affected area according to product labeling. | Use only as directed on the age-appropriate product label. |
238. Neomycin/Polymyxin B/Bacitracin
Generic name: Neomycin + polymyxin B + bacitracin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Minor superficial skin wounds | Apply a thin layer as directed by the product label; avoid prolonged or extensive use. | Use only according to age-specific product labeling; avoid large areas or deep wounds. |
239. Clindamycin (Topical)
Generic name: Clindamycin phosphate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acne vulgaris; selected superficial skin infections | Apply 1% topical formulation once or twice daily according to product instructions. | Age and formulation restrictions apply; clinician-directed use. |
240. Erythromycin (Topical)
Generic name: Erythromycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acne vulgaris; selected superficial skin infections | Apply 2% topical formulation once or twice daily as directed. | Age-appropriate topical use under clinician guidance. |
241. Metronidazole (Topical)
Generic name: Metronidazole
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected inflammatory skin conditions; topical rosacea products are not general infection treatment | Apply the prescribed topical strength once or twice daily according to product label. | Not routinely established for children; specialist advice required. |
242. Dapsone (Topical)
Generic name: Dapsone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acne vulgaris; not a general antibacterial skin treatment | Apply the prescribed gel strength once or twice daily according to labeling. | Age restrictions vary by formulation; clinician-directed use only. |
243. Erythromycin Ophthalmic
Generic name: Erythromycin ophthalmic ointment
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis; neonatal eye prophylaxis where indicated | Apply a small ribbon to the affected eye up to 6 times daily, depending on severity and label. | Use age-specific ophthalmic instructions; newborn prophylaxis follows local protocol. |
244. Tobramycin Ophthalmic
Generic name: Tobramycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis and other susceptible external eye infections | Instill 1–2 drops every 4 hours for mild to moderate infection; severe cases require specialist directions. | Use only in approved age groups; pediatric ophthalmic dosing depends on severity. |
245. Gentamicin Ophthalmic
Generic name: Gentamicin sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis; susceptible external eye infections | Instill 1–2 drops every 4 hours; severe infections may require more frequent initial dosing under ophthalmologist direction. | Age-specific ophthalmic guidance required. |
246. Ciprofloxacin Ophthalmic
Generic name: Ciprofloxacin hydrochloride
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis; corneal ulcer | Conjunctivitis: commonly 1–2 drops every 2 hours initially, then reduce frequency; corneal ulcer requires intensive specialist dosing. | Use age- and diagnosis-specific ophthalmic labeling; corneal ulcer requires specialist care. |
247. Ofloxacin Ophthalmic
Generic name: Ofloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis; corneal ulcer | Conjunctivitis: 1–2 drops every 2–4 hours initially, then reduce according to response and label. | Age-specific product labeling required; specialist dosing for corneal ulcer. |
248. Moxifloxacin Ophthalmic
Generic name: Moxifloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Instill 1 drop three times daily for the labeled treatment course. | Use only according to local age approval and product labeling. |
249. Besifloxacin Ophthalmic
Generic name: Besifloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Instill 1 drop three times daily for 7 days, according to product labeling. | Follow local product age approval and pediatric ophthalmic instructions. |
250. Gatifloxacin Ophthalmic
Generic name: Gatifloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Instill according to concentration-specific product labeling, commonly every 2 hours initially then less frequently. | Use age-specific product labeling; formulation strengths differ. |
251. Azithromycin Ophthalmic
Generic name: Azithromycin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Use the labeled ophthalmic schedule for the available concentration and formulation. | Use only in approved age groups and according to the product label. |
252. Chloramphenicol Ophthalmic
Generic name: Chloramphenicol
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis and susceptible superficial eye infections | Drops or ointment according to local product labeling and treatment duration. | Age restrictions vary by country; do not use in newborns unless specifically directed. |
253. Sulfacetamide Ophthalmic
Generic name: Sulfacetamide sodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis; superficial eye infections | Instill drops at the frequency stated on the product label, then reduce as symptoms improve. | Use only if approved for the child’s age and clinical indication. |
254. Polymyxin B/Trimethoprim Ophthalmic
Generic name: Polymyxin B + trimethoprim
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Instill 1 drop every 3 hours, up to 6 doses daily, according to product labeling. | Use only in approved age groups; follow pediatric product instructions. |
255. Bacitracin Ophthalmic
Generic name: Bacitracin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Susceptible superficial bacterial eye infections | Apply ophthalmic ointment as directed by the product label. | Use only under age-appropriate ophthalmic guidance. |
256. Neomycin/Polymyxin B/Dexamethasone Ophthalmic
Generic name: Neomycin + polymyxin B + dexamethasone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Steroid-responsive ocular inflammation when bacterial infection is present or at risk | Ophthalmologist-directed dosing only; steroid-containing eye medicines require examination and monitoring. | Specialist ophthalmologist dosing only; not for unsupervised use. |
257. Ciprofloxacin Otic
Generic name: Ciprofloxacin otic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Otitis externa; selected middle-ear infections with tubes | Use concentration- and indication-specific ear-drop schedule from the product label. | Age- and indication-specific otic labeling required. |
258. Ofloxacin Otic
Generic name: Ofloxacin otic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Otitis externa; chronic suppurative otitis media in selected patients | Instill the labeled number of drops once or twice daily depending on diagnosis. | Use age- and diagnosis-specific product labeling. |
259. Neomycin/Polymyxin B/Hydrocortisone Otic
Generic name: Neomycin + polymyxin B + hydrocortisone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Otitis externa with inflammation | Instill the labeled number of drops 3–4 times daily for the prescribed short course; check tympanic membrane status. | Use only where age-approved; avoid if tympanic membrane perforation is suspected unless specialist-directed. |
260. Ciprofloxacin/Dexamethasone Otic
Generic name: Ciprofloxacin + dexamethasone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute otitis externa; otorrhea in children with tympanostomy tubes | Instill 4 drops twice daily for the labeled course. | Use only in approved age groups; commonly 4 drops twice daily for the labeled course. |
261. Neomycin/Polymyxin B Otic
Generic name: Neomycin + polymyxin B
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Susceptible bacterial otitis externa | Use the labeled ear-drop schedule for the prescribed duration; check tympanic membrane integrity. | Age-specific label and clinician assessment required. |
262. Bacitracin/Polymyxin B Ophthalmic
Generic name: Bacitracin + polymyxin B
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Susceptible superficial external eye infections | Apply ophthalmic ointment according to product label and clinical assessment. | Use only under age-appropriate ophthalmic guidance. |
263. Chloramphenicol (Topical Skin)
Generic name: Chloramphenicol topical
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected localized bacterial skin infections where licensed | Use only according to local product label and antimicrobial guidance. | Not routinely recommended; specialist advice required. |
264. Fusidic Acid (Ophthalmic)
Generic name: Fusidic acid ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis caused by susceptible organisms | Apply or instill the ophthalmic formulation according to local product instructions. | Follow country-specific age approval and ophthalmic guidance. |
265. Sulfacetamide (Topical Skin)
Generic name: Sulfacetamide sodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected skin conditions; not a substitute for systemic treatment of invasive infection | Apply the prescribed topical preparation according to the product label. | Not routinely established; clinician-directed use only. |
266. Clioquinol (Topical)
Generic name: Clioquinol
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected localized skin infections, where licensed | Apply topical preparation according to local product labeling; avoid prolonged use. | Age-specific labeling and clinician advice required. |
267. Neomycin (Topical)
Generic name: Neomycin sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Minor superficial skin wounds; selected topical preparations | Apply a thin layer according to product label; avoid extensive or prolonged use. | Use only according to age-appropriate product instructions. |
268. Polymyxin B (Topical)
Generic name: Polymyxin B
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Minor superficial skin wounds in combination products | Apply a thin layer as directed by the specific topical product label. | Use only according to age-specific product instructions. |
269. Bacitracin Zinc
Generic name: Bacitracin zinc
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Minor superficial skin wounds | Apply a thin layer according to the product label. | Use only as directed by age-appropriate labeling. |
270. Retapamulin (Topical Ointment)
Generic name: Retapamulin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Impetigo caused by susceptible organisms | Apply 1% ointment twice daily for 5 days where licensed. | Use only for approved pediatric age groups and labeled duration. |
271. Ozenoxacin (Topical Cream)
Generic name: Ozenoxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Impetigo | Apply 1% cream twice daily for 5 days according to labeling. | Follow local age approval and product instructions. |
272. Mupirocin Nasal
Generic name: Mupirocin calcium nasal
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Nasal carriage of Staphylococcus aureus, including MRSA decolonization protocols | Apply the prescribed nasal ointment inside each nostril twice daily for the labeled course. | Pediatric decolonization is protocol-dependent; specialist guidance required. |
273. Neomycin/Polymyxin B/Hydrocortisone (Ophthalmic)
Generic name: Neomycin + polymyxin B + hydrocortisone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected ocular inflammation with susceptible bacterial infection | Ophthalmologist-directed only; dosing depends on formulation and examination. | Specialist ophthalmologist direction required. |
274. Ciprofloxacin/Fluocinolone Otic
Generic name: Ciprofloxacin + fluocinolone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute otitis externa; selected middle-ear infections | Use the product-specific labeled number of drops and course. | Age- and diagnosis-specific product labeling required. |
275. Gentamicin (Topical Skin)
Generic name: Gentamicin sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected localized susceptible bacterial skin infections | Apply the prescribed topical preparation according to product labeling. | Age-specific use and formulation guidance required. |
276. Neomycin/Polymyxin B/Hydrocortisone (Otic Suspension)
Generic name: Neomycin + polymyxin B + hydrocortisone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Inflammatory bacterial otitis externa | Use the product-specific ear-drop schedule; check tympanic membrane before treatment. | Age-specific labeling required; avoid unsupervised use with suspected perforation. |
277. Polymyxin B/Neomycin Ophthalmic
Generic name: Polymyxin B + neomycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Susceptible external bacterial eye infections | Use ophthalmic drops or ointment according to product label and clinician instructions. | Age-pecific ophthalmic guidance required. |
278. Framycetin (Topical)
Generic name: Framycetin sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected localized skin or superficial wound infections | Apply according to local formulation instructions and antimicrobial guidance. | Use only under age-appropriate clinician guidance. |
279. Framycetin (Ophthalmic)
Generic name: Framycetin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible external eye infections | Use the product-specific ophthalmic dose and course. | Pediatric ophthalmic guidance and local age approval required. |
280. Fusidic Acid (Cream)
Generic name: Fusidic acid 2%
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Localized impetigo and susceptible superficial skin infections | Apply a thin layer 2–3 times daily for a short course as directed by local guidance. | Use age-appropriate formulation and local label instructions. |
281. Mupirocin Calcium
Generic name: Mupirocin calcium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Impetigo and selected localized bacterial skin infections | Apply the labeled topical formulation to the affected area as directed. | Use only in approved age groups and according to the local label. |
282. Silver Sulfadiazine 1% Cream
Generic name: Silver sulfadiazine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Burn wound infection prevention and treatment | Apply to the affected burn surface according to burn-care protocol. | Not for premature infants or newborns; pediatric burn specialist required. |
283. Mafenide Acetate 5% Solution
Generic name: Mafenide acetate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Burn wound infection prevention | Apply dressings soaked in solution according to specialist burn-unit protocol. | Specialist pediatric burn-unit protocol required. |
284. Chlorhexidine (Antiseptic)
Generic name: Chlorhexidine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Skin antisepsis and infection prevention; not a systemic antibiotic | Use the concentration and application schedule specified for the product and procedure. | Age-specific restrictions apply; avoid inappropriate use in neonates and near eyes or ears. |
285. Povidone-Iodine (Antiseptic)
Generic name: Povidone-iodine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Skin and wound antisepsis; not a systemic antibiotic | Apply the formulation according to procedure-specific product instructions. | Age and thyroid-related precautions apply; pediatric clinician guidance required. |
286. Nitrofural (Nitrofurazone)
Generic name: Nitrofurazone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected superficial wound and burn infections where licensed | Apply topical preparation according to local product labeling and wound-care guidance. | Not routinely established; pediatric specialist advice required. |
287. Bacitracin/Neomycin/Polymyxin B Ophthalmic Ointment
Generic name: Bacitracin + neomycin + polymyxin B
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Susceptible superficial external eye infections | Apply ophthalmic ointment according to product label and clinician instructions. | Use only under age-appropriate ophthalmic guidance. |
288. Tobramycin/Dexamethasone Ophthalmic
Generic name: Tobramycin + dexamethasone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Steroid-responsive ocular inflammation with bacterial infection or risk | Ophthalmologist-directed dosing only; monitor intraocular pressure and infection status. | Specialist ophthalmologist direction required. |
289. Neomycin/Polymyxin B/Dexamethasone Ophthalmic Ointment
Generic name: Neomycin + polymyxin B + dexamethasone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected ocular inflammatory conditions with bacterial infection risk | Use only under ophthalmologist direction; ointment frequency is individualized. | Specialist ophthalmologist direction required. |
290. Polymyxin B/Trimethoprim Eye Drops
Generic name: Polymyxin B + trimethoprim
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute bacterial conjunctivitis | Instill 1 drop every 3 hours, up to 6 doses daily, according to product labeling. | Use only in approved age groups and according to label. |
291. Ofloxacin Eye Drops
Generic name: Ofloxacin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis and corneal ulcer | Use the indication-specific labeled schedule; corneal ulcer requires intensive ophthalmologist-supervised dosing. | Age- and diagnosis-specific ophthalmic guidance required. |
292. Ciprofloxacin Eye Drops
Generic name: Ciprofloxacin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis and corneal ulcer | Follow concentration- and diagnosis-specific labeling; corneal ulcer needs specialist dosing. | Use age- and diagnosis-specific ophthalmic instructions. |
293. Tobramycin Eye Drops
Generic name: Tobramycin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Use product-specific dosing; severe infection may require more frequent initial administration under specialist supervision. | Use age-specific product labeling and clinician guidance. |
294. Gentamicin Eye Drops
Generic name: Gentamicin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Use product-specific ophthalmic dosing and treatment duration. | Age-specific ophthalmic guidance required. |
295. Moxifloxacin Eye Drops
Generic name: Moxifloxacin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Instill 1 drop three times daily for the labeled treatment course. | Follow local age approval and pediatric product instructions. |
296. Besifloxacin Eye Drops
Generic name: Besifloxacin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Instill 1 drop three times daily for 7 days according to product labeling. | Use only where approved for the child’s age. |
297. Gatifloxacin Eye Drops
Generic name: Gatifloxacin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Use concentration-specific product instructions; schedules vary by formulation. | Age-specific product label required. |
298. Chloramphenicol Eye Ointment
Generic name: Chloramphenicol ophthalmic ointment
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Apply the labeled amount to the affected eye at the recommended intervals. | Age restrictions vary; newborn use requires specific medical direction. |
299. Azithromycin Eye Drops
Generic name: Azithromycin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Follow the product-specific ophthalmic loading and continuation schedule. | Use only for approved ages and according to local product labeling. |
300. Sulfacetamide Eye Drops
Generic name: Sulfacetamide sodium ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis and susceptible superficial eye infections | Instill according to the product-specific dosing schedule and treatment duration. | Use only where approved for the child’s age and diagnosis. |
301. Cefepime/Enmetazobactam
Generic name: Cefepime + enmetazobactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated urinary tract infections, including pyelonephritis | 2.5 g IV every 8 hours over 2 hours for the labeled course; adjust for renal function. | Not established; specialist-directed use only. |
302. Cefepime/Taniborbactam
Generic name: Cefepime + taniborbactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected complicated urinary infections caused by resistant Gram-negative bacteria | Use only according to current local approval and product-specific prescribing information. | Not established; specialist-directed use only. |
303. Cefepime/Zidebactam
Generic name: Cefepime + zidebactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Investigational or jurisdiction-dependent treatment of resistant Gram-negative infections | No universal approved dose; use only under an applicable clinical protocol or product label. | Not established; specialist-directed use only. |
304. Aztreonam/Avibactam
Generic name: Aztreonam + avibactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected serious infections caused by metallo-beta-lactamase-producing Gram-negative bacteria | Use current country-specific approved product information; specialist dosing and renal adjustment required. | Not established for routine pediatric use; specialist-directed only. |
305. Sulbactam
Generic name: Sulbactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible bacterial infections; often used in combination with ampicillin | Dose depends on the combination product and infection; follow its specific prescribing information. | Weight-based dosing according to the combination product and pediatric indication. |
306. Ampicillin/Sulbactam
Generic name: Ampicillin + sulbactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Skin and soft-tissue infections; intra-abdominal and selected respiratory infections | Common adult regimen: 1.5–3 g IV every 6 hours; adjust for renal function and indication. | Common reference regimen: 200–300 mg/kg/day of the combined product IV in divided doses; specialist verification required. |
307. Piperacillin/Tazobactam
Generic name: Piperacillin + tazobactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Severe intra-abdominal, urinary, skin, and hospital-acquired infections | Common adult regimen: 3.375–4.5 g IV every 6–8 hours, depending on indication and infusion protocol; adjust for renal function. | Weight-based IV dosing according to indication, age, renal function, and maximum dose. |
308. Ticarcillin/Clavulanate
Generic name: Ticarcillin + clavulanate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected serious susceptible Gram-negative and mixed infections | Use only where available; dose according to product labeling, infection severity, and renal function. | Weight-based specialist dosing; availability and recommendations vary by country. |
309. Amoxicillin/Clavulanate (Intravenous)
Generic name: Amoxicillin + clavulanate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Severe susceptible respiratory, skin, dental, and intra-abdominal infections | Use the locally licensed IV formulation and indication-specific schedule; adjust for renal function. | Weight-based dosing based on the amoxicillin component and the specific formulation. |
310. Cefoperazone/Sulbactam
Generic name: Cefoperazone + sulbactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Respiratory, urinary, intra-abdominal, and skin infections caused by susceptible organisms | Dose depends on the product ratio and infection; follow local prescribing information. | Weight-based specialist dosing; verify the sulbactam and cefoperazone components. |
311. Ceftriaxone/Sulbactam
Generic name: Ceftriaxone + sulbactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible respiratory, urinary, and intra-abdominal infections | Combination ratios and approved uses vary; follow the exact product label and local antimicrobial guidance. | Weight-based dosing under pediatric supervision; verify each component and age restrictions. |
312. Cefixime/Clavulanate
Generic name: Cefixime + clavulanate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible respiratory or urinary infections where this combination is licensed | Follow the exact locally approved combination product; do not assume equivalence with cefixime alone. | Not standardized across products; pediatric prescriber must verify formulation and dose. |
313. Cefpodoxime/Clavulanate
Generic name: Cefpodoxime + clavulanate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible respiratory infections where licensed | Use only according to the specific combination product label and local guidelines. | Not standardized; verify age, weight, and exact formulation with a pediatric prescriber. |
314. Cefuroxime Axetil
Generic name: Cefuroxime axetil
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Sinusitis, otitis media, respiratory, skin, and urinary infections | Common adult dose: 250–500 mg orally every 12 hours, depending on infection. | Common reference dose: 10–15 mg/kg per dose orally every 12 hours, depending on indication and maximum dose. |
315. Cefaclor
Generic name: Cefaclor
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Otitis media, respiratory, skin, and urinary infections | Common adult dose: 250–500 mg orally every 8 hours, depending on infection. | Common reference dose: 20–40 mg/kg/day orally in divided doses; maximum dose and age limits apply. |
316. Cefprozil
Generic name: Cefprozil
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Sinusitis, otitis media, pharyngitis, and skin infections | Common adult dose: 250–500 mg orally every 12–24 hours, depending on indication. | Common reference dose: 7.5–15 mg/kg per dose orally every 12 hours, depending on indication. |
317. Cefditoren Pivoxil
Generic name: Cefditoren pivoxil
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Community-acquired pneumonia; pharyngitis; skin infections | Common adult dose: 200–400 mg orally every 12 hours with food, according to indication and local approval. | Pediatric use and availability vary; follow local product labeling. |
318. Cefpodoxime Proxetil
Generic name: Cefpodoxime proxetil
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Respiratory, urinary, and skin infections | Common adult dose: 100–200 mg orally every 12 hours, depending on infection. | Common reference dose: 5 mg/kg per dose orally every 12 hours; maximum dose and age limits apply. |
319. Cefotiam
Generic name: Cefotiam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected respiratory, urinary, and surgical infections where available | Use the locally approved IV or oral product information; dosing differs by formulation and indication. | Weight-based specialist dosing; local pediatric labeling required. |
320. Cefmetazole
Generic name: Cefmetazole
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected intra-abdominal, pelvic, and surgical infections | Use local product labeling and infection-specific protocols; renal adjustment may be required. | Weight-based specialist dosing only. |
321. Cefminox
Generic name: Cefminox
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected abdominal, pelvic, and biliary infections where licensed | Follow local prescribing information; use indication-specific and renal-adjusted dosing. | Pediatric regimen not standardized internationally; specialist guidance required. |
322. Cefotetan
Generic name: Cefotetan
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Intra-abdominal, pelvic, and surgical prophylaxis indications | Common adult treatment regimens use 1–2 g IV every 12 hours; prophylaxis uses a separate protocol. | Weight-based specialist dosing; pediatric approval and protocols vary. |
323. Cefotaxime
Generic name: Cefotaxime
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Severe respiratory, urinary, bloodstream, and central nervous system infections | Common adult dosing: 1–2 g IV every 6–8 hours; meningitis and severe infections require specific protocols. | Neonatal and pediatric dosing varies substantially by age and indication; use pediatric reference guidance. |
324. Cefoperazone
Generic name: Cefoperazone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Susceptible respiratory, urinary, biliary, and intra-abdominal infections | Common adult regimens use 1–2 g IV every 12 hours; indication and hepatic function affect dosing. | Weight-based specialist dosing; monitor hepatic and coagulation parameters where indicated. |
325. Cefotiam Hexetil
Generic name: Cefotiam hexetil
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected upper and lower respiratory infections where licensed | Follow the locally approved oral product label; schedules vary by country. | Pediatric use depends on local approval and formulation; weight-based prescriber guidance required. |
326. Cefixime
Generic name: Cefixime
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected urinary and respiratory infections; selected sexually transmitted infections only where guideline-supported | Common adult dose: 400 mg orally once daily or 200 mg every 12 hours, depending on indication. | Common reference dose: 8 mg/kg/day orally once daily or divided every 12 hours; maximum 400 mg/day. |
327. Cefalexin (Cephalexin)
Generic name: Cephalexin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Skin, soft-tissue, and selected urinary infections | Common adult dose: 250–500 mg orally every 6–12 hours, depending on infection. | Common reference dose: 25–50 mg/kg/day orally in divided doses; higher doses may be used for selected indications. |
328. Cefradine (Cephradine)
Generic name: Cephradine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Susceptible respiratory, skin, and urinary infections | Use the locally approved oral or injectable product label; dose depends on infection and renal function. | Weight-based dosing according to pediatric product information. |
329. Cefadroxil
Generic name: Cefadroxil
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Skin and soft-tissue infections; selected urinary infections; streptococcal pharyngitis | Common adult dose: 500 mg every 12 hours or 1 g once daily, depending on indication. | Common reference dose: 30 mg/kg/day orally in one or two divided doses; maximum dose depends on indication. |
330. Cefazolin
Generic name: Cefazolin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Skin, soft-tissue, bone, joint, and surgical prophylaxis indications | Common adult treatment dose: 1–2 g IV every 8 hours; surgical prophylaxis uses a separate protocol. | Weight-based IV dosing; neonatal schedules differ by gestational and postnatal age. |
331. Cefalotin (Cephalothin)
Generic name: Cephalothin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible Gram-positive and other bacterial infections where available | Use the locally approved injectable product label; dosing depends on infection severity and renal function. | Weight-based specialist dosing; local pediatric guidance required. |
332. Cefradine Injection
Generic name: Cephradine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Susceptible respiratory, urinary, and skin infections | Follow the specific injectable formulation label and local treatment guidance. | Weight-based dosing; specialist verification required. |
333. Cefalexin Oral Suspension
Generic name: Cephalexin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Pediatric skin, throat, and selected urinary infections | Adults generally use capsules or tablets; dose according to indication. | Calculate from the prescribed mg/kg/day and the suspension concentration; verify maximum dose before measuring in mL. |
334. Cefuroxime Sodium
Generic name: Cefuroxime sodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Pneumonia, meningitis, urinary, and other susceptible infections | Common adult IV dose: 750 mg–1.5 g every 8 hours, depending on infection. | Weight- and age-based IV dosing; meningitis and neonatal treatment require specialist protocols. |
335. Ceftriaxone
Generic name: Ceftriaxone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Pneumonia, meningitis, bloodstream, urinary, and other susceptible infections | Common adult dose: 1–2 g IV/IM every 24 hours; meningitis and other severe infections require specific protocols. | Weight-based IV/IM dosing; neonatal restrictions and calcium-related precautions apply. |
336. Ceftazidime
Generic name: Ceftazidime
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Serious Gram-negative infections, including susceptible Pseudomonas infections | Common adult dose: 1–2 g IV every 8–12 hours; adjust for renal function and infection site. | Weight- and age-based dosing; neonatal dosing differs from older children. |
337. Cefepime
Generic name: Cefepime
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Hospital-acquired pneumonia; febrile neutropenia; serious Gram-negative infections | Common adult dose: 1–2 g IV every 8–12 hours, depending on indication; adjust for renal function. | Common reference dose: 50 mg/kg per dose IV every 8–12 hours, depending on indication and maximum dose. |
338. Cefixime Dispersible Tablets
Generic name: Cefixime
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible respiratory and urinary infections | Common adult dose: 400 mg daily or 200 mg every 12 hours, according to indication. | Common reference dose: 8 mg/kg/day; calculate using the actual tablet strength and verify maximum dose. |
339. Cefuroxime Axetil Suspension
Generic name: Cefuroxime axetil
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Otitis media, sinusitis, and selected respiratory infections | Adults generally use tablets; follow the indication-specific oral regimen. | Common reference dose: 10–15 mg/kg per dose every 12 hours, depending on indication and maximum dose. |
340. Cefpodoxime Suspension
Generic name: Cefpodoxime proxetil
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Otitis media, sinusitis, and selected respiratory infections | Common adult dose: 100–200 mg every 12 hours, depending on indication. | Common reference dose: 5 mg/kg per dose every 12 hours; maximum dose and age limits apply. |
341. Azithromycin
Generic name: Azithromycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected respiratory infections; selected sexually transmitted infections under current guidelines | Common respiratory regimen: 500 mg on day 1, then 250 mg daily on days 2–5; indication-specific regimens differ. | Common reference regimen: 10 mg/kg on day 1, then 5 mg/kg daily on days 2–5 for selected indications; maximum doses apply. |
342. Clarithromycin
Generic name: Clarithromycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Respiratory infections; selected Helicobacter pylori combination regimens | Common adult dose: 250–500 mg orally every 12 hours; H. pylori regimens require combination therapy. | Common reference dose: 7.5 mg/kg per dose every 12 hours; maximum dose and indication-specific restrictions apply. |
343. Erythromycin
Generic name: Erythromycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected respiratory, skin, and susceptible bacterial infections | Dose depends on salt and formulation; common adult regimens use divided oral doses. | Weight-based dosing by indication and formulation; neonatal use requires special caution. |
344. Roxithromycin
Generic name: Roxithromycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected respiratory and skin infections where licensed | Common adult regimen: 150 mg orally every 12 hours or 300 mg daily, where approved. | Weight-based local product guidance required; pediatric approval varies by country. |
345. Spiramycin
Generic name: Spiramycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible respiratory and oral infections; selected pregnancy toxoplasmosis protocols | Dose depends on indication and country-specific formulation; follow local prescribing information. | Weight-based specialist dosing; pregnancy-related protocols are not pediatric treatment regimens. |
346. Josamycin
Generic name: Josamycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible respiratory and skin infections where licensed | Follow the local product label; dose and frequency vary by formulation and indication. | Weight-based dosing under local pediatric guidance. |
347. Telithromycin
Generic name: Telithromycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Community-acquired pneumonia where still licensed and appropriate | 800 mg orally once daily for the labeled course; major safety restrictions and interactions apply. | Not established for routine pediatric use; avoid unless specialist-directed under applicable guidance. |
348. Doxycycline
Generic name: Doxycycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Tick-borne infections, atypical respiratory infections, acne, and selected other infections | Common adult dose: 100 mg orally or IV every 12 hours; indication-specific duration applies. | Weight-based dosing; short-course use is accepted for selected serious infections in children of all ages under guideline direction. |
349. Minocycline
Generic name: Minocycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acne; selected susceptible bacterial infections | Common adult regimen: 100 mg orally every 12 hours after any required loading dose; indication and formulation matter. | Generally avoid routine use in children under 8 years; older pediatric use requires specialist guidance. |
350. Tigecycline
Generic name: Tigecycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated skin and intra-abdominal infections; selected community-acquired pneumonia | 100 mg IV loading dose, then 50 mg IV every 12 hours; indication and safety warnings apply. | Not routinely recommended; use only when no suitable alternative and under specialist direction. |
351. Omadacycline Oral
Generic name: Omadacycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Community-acquired bacterial pneumonia; acute bacterial skin infections | 300 mg orally once daily after the labeled oral loading schedule; administer fasting and follow product instructions. | Not established; specialist-directed use only. |
352. Eravacycline IV
Generic name: Eravacycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated intra-abdominal infections | 1 mg/kg IV every 12 hours. | Not established; specialist-directed use only. |
353. Sarecycline
Generic name: Sarecycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Inflammatory acne vulgaris | Oral dose is weight-band based and taken once daily according to product labeling. | Approved age and weight bands vary by jurisdiction; use exact product label. |
354. Lefamulin IV
Generic name: Lefamulin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Community-acquired bacterial pneumonia | 150 mg IV every 12 hours; switch to oral therapy only according to approved labeling and clinical status. | Not established; specialist-directed use only. |
355. Delafloxacin IV
Generic name: Delafloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute bacterial skin and skin-structure infections; community-acquired pneumonia | 300 mg IV every 12 hours; adjust or select route according to renal function and label. | Not established for routine pediatric use. |
356. Linezolid
Generic name: Linezolid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| MRSA and VRE infections; pneumonia; complicated skin infections | Common adult dose: 600 mg orally or IV every 12 hours. | Children under 12 years commonly require 10 mg/kg per dose every 8 hours; age-specific maximum and monitoring apply. |
357. Tedizolid
Generic name: Tedizolid phosphate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute bacterial skin and skin-structure infections | 200 mg orally or IV once daily for 6 days, where licensed. | Pediatric dosing depends on age and weight; verify current local product label. |
358. Daptomycin
Generic name: Daptomycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated skin infections; Staphylococcus aureus bloodstream infection and right-sided endocarditis | Dose depends on indication; common adult regimens range from 4–10 mg/kg IV every 24 hours under specialist guidance. | Age- and indication-specific weight-based dosing; specialist monitoring required. |
359. Dalbavancin
Generic name: Dalbavancin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute bacterial skin and skin-structure infections | Common adult options: 1,500 mg IV once or 1,000 mg IV followed by 500 mg one week later; renal adjustment may apply. | Pediatric use depends on age and weight; specialist and current label guidance required. |
360. Oritavancin
Generic name: Oritavancin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute bacterial skin and skin-structure infections | 1,200 mg IV once over the labeled infusion period. | Not established for routine pediatric use. |
361. Telavancin
Generic name: Telavancin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated skin infections; hospital-acquired bacterial pneumonia caused by susceptible Gram-positive organisms | 10 mg/kg IV every 24 hours for labeled indications; renal adjustment and safety monitoring required. | Not established for routine pediatric use. |
362. Quinupristin/Dalfopristin
Generic name: Quinupristin + dalfopristin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected serious resistant Gram-positive infections, including susceptible VRE | 7.5 mg/kg IV every 8–12 hours depending on infection; specialist monitoring required. | Not established for routine pediatric use; specialist-directed only. |
363. Chloramphenicol (Systemic)
Generic name: Chloramphenicol
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected severe infections when safer alternatives are unsuitable | Specialist-directed dosing with blood-count and drug-level monitoring; toxicity risk is significant. | Neonatal dosing is especially hazardous; specialist-only use with careful monitoring. |
364. Spectinomycin
Generic name: Spectinomycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected gonococcal infections where available and guideline-supported | Historically 2 g IM once for selected adult indications; current resistance and guideline recommendations must be checked. | Not a routine pediatric regimen; specialist and current guideline direction required. |
365. Nitrofurantoin
Generic name: Nitrofurantoin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Uncomplicated lower urinary tract infection | Modified-release: 100 mg orally every 12 hours for the locally recommended course; renal function and formulation matter. | Weight-based dosing for eligible children; avoid in infants under 1 month and follow local restrictions. |
366. Fosfomycin Trometamol (Oral)
Generic name: Fosfomycin trometamol
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Uncomplicated lower urinary tract infection in eligible patients | 3 g orally once for the approved uncomplicated cystitis indication. | Pediatric use is not routinely established in many jurisdictions; specialist guidance required. |
367. Trimethoprim
Generic name: Trimethoprim
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Uncomplicated urinary tract infections caused by susceptible organisms | Common adult regimen: 200 mg orally every 12 hours where local resistance supports its use. | Weight-based dosing according to age, indication, and local pediatric guidance. |
368. Trimethoprim/Sulfamethoxazole
Generic name: Trimethoprim + sulfamethoxazole
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Urinary, skin, and selected respiratory infections; Pneumocystis treatment or prevention | Dose depends on indication; common uncomplicated infection regimen is one double-strength tablet orally every 12 hours. | Dose by trimethoprim component and indication; neonatal restrictions and age-specific protocols apply. |
369. Sulfadiazine
Generic name: Sulfadiazine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected toxoplasmosis combination regimens and other specialist indications | Use only as part of an indication-specific combination regimen; monitor renal function and blood counts. | Specialist weight-based regimen; avoid in newborns and follow strict age restrictions. |
370. Sulfisoxazole
Generic name: Sulfisoxazole
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected susceptible urinary infections where available | Use only where licensed and supported by susceptibility results; follow product-specific dosing. | Not for routine pediatric use without specialist review; newborn restrictions apply. |
371. Dapsone (Oral)
Generic name: Dapsone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Leprosy multidrug therapy; selected Pneumocystis prophylaxis protocols | Dose depends on the multidrug regimen and indication; check G6PD status and monitor blood counts. | Weight-based specialist regimen; monitor for hemolysis and methemoglobinemia. |
372. Rifampicin (Rifampin)
Generic name: Rifampicin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Tuberculosis; selected prophylaxis and combination treatment indications | Use only in the appropriate combination or prophylaxis regimen; dose and duration depend on indication. | Weight-based regimen under national TB or infectious-disease guidance. |
373. Isoniazid
Generic name: Isoniazid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Tuberculosis treatment and latent tuberculosis regimens | Use the appropriate national TB regimen; pyridoxine may be indicated for patients at risk of neuropathy. | Weight-based TB regimen; pediatric maximum doses and schedule depend on regimen. |
374. Pyrazinamide
Generic name: Pyrazinamide
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Active tuberculosis as part of combination treatment | Weight-band dosing in the intensive phase of the approved TB regimen; monitor liver function. | Weight-band pediatric TB regimen under national program guidance. |
375. Ethambutol
Generic name: Ethambutol
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Active tuberculosis as part of combination treatment | Weight-based TB regimen; adjust for renal function and monitor visual acuity and color vision. | Weight-based specialist TB regimen; visual monitoring is essential when feasible. |
376. Bedaquiline
Generic name: Bedaquiline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Drug-resistant tuberculosis as part of an approved combination regimen | Use the approved loading and continuation schedule; monitor ECG, QT interval, and liver function. | Age- and weight-specific TB specialist regimen required. |
377. Delamanid
Generic name: Delamanid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Drug-resistant tuberculosis as part of a combination regimen | Use current national TB protocol; ECG and QT monitoring required. | Age- and weight-specific specialist TB regimen required. |
378. Pretomanid
Generic name: Pretomanid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected drug-resistant tuberculosis combination regimens | 200 mg orally once daily within the approved combination regimen; never use as monotherapy. | Not established for routine pediatric use; specialist TB team required. |
379. Cycloserine
Generic name: Cycloserine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Drug-resistant tuberculosis combination regimens | Specialist-directed oral dosing with renal, serum-level, and neuropsychiatric monitoring. | Weight-based specialist TB regimen only. |
380. Ethionamide
Generic name: Ethionamide
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Drug-resistant tuberculosis combination regimens | Specialist-directed divided oral dosing; monitor liver function and gastrointestinal tolerance. | Weight-based specialist TB regimen only. |
381. Para-Aminosalicylic Acid
Generic name: Para-aminosalicylic acid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Drug-resistant tuberculosis combination regimens | Use formulation-specific specialist dosing and current national TB protocol. | Weight-based specialist TB regimen only. |
382. Clofazimine
Generic name: Clofazimine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Leprosy multidrug therapy; selected drug-resistant TB regimens | Use the indication-specific multidrug schedule; monitor for adverse effects and interactions. | Weight-based specialist regimen; national program guidance required. |
383. Rifabutin
Generic name: Rifabutin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Tuberculosis and selected Mycobacterium avium complex regimens | Common adult dose: 300 mg orally daily for selected indications; interactions and regimen-specific adjustments apply. | Weight-based specialist dosing; check drug interactions and local guidance. |
384. Rifapentine
Generic name: Rifapentine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Latent tuberculosis and selected active TB regimens | Use only within an approved regimen; weekly and daily schedules differ by indication. | Weight-based TB regimen under national program guidance. |
385. Streptomycin
Generic name: Streptomycin sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected tuberculosis and other specialist-managed infections | Use indication-specific specialist dosing with renal and hearing monitoring. | Weight-based specialist dosing only. |
386. Amikacin
Generic name: Amikacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Serious Gram-negative infections; selected mycobacterial infections | Weight-based IV dosing with renal function and drug-level monitoring; regimen depends on infection. | Age- and weight-based dosing with therapeutic drug monitoring; neonatal dosing differs. |
387. Gentamicin (Systemic)
Generic name: Gentamicin sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Serious Gram-negative infections; selected combination regimens | Use weight-based extended-interval or divided dosing with renal function and serum-level monitoring. | Age- and weight-based neonatal or pediatric dosing with drug-level monitoring. |
388. Tobramycin (Systemic)
Generic name: Tobramycin sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Serious susceptible Gram-negative infections; selected Pseudomonas infections | Weight-based IV dosing with therapeutic drug and renal monitoring; individualized regimen required. | Weight- and age-based specialist dosing with serum-level monitoring. |
389. Netilmicin
Generic name: Netilmicin sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected serious Gram-negative infections where available | Weight-based specialist dosing with renal and serum-level monitoring. | Age- and weight-based specialist dosing only. |
390. Kanamycin
Generic name: Kanamycin sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Limited specialist indications; historical use in resistant tuberculosis | Not routinely recommended for TB in current guidance; specialist-only use where an approved indication remains. | Not for routine pediatric use; specialist-directed only. |
391. Paromomycin
Generic name: Paromomycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Intestinal amoebiasis and selected parasitic infections; not a routine systemic antibacterial | Dose and duration depend on the parasitic indication and formulation; follow specialist protocol. | Weight-based indication-specific dosing; pediatric specialist guidance required. |
392. Neomycin (Oral)
Generic name: Neomycin sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected bowel decontamination protocols; hepatic encephalopathy adjunct in limited settings | Use only for specific labeled or specialist-directed indications; systemic toxicity can occur. | Not for routine pediatric use; specialist-directed only. |
393. Bacitracin (Oral)
Generic name: Bacitracin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Historical or limited bowel-related indications; not routine systemic treatment | Not routinely recommended; use only where a specific local product label and specialist indication support it. | Not established for routine pediatric use. |
394. Colistin (Colistimethate Sodium)
Generic name: Colistimethate sodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Serious multidrug-resistant Gram-negative infections | Individualized loading and maintenance regimen based on renal function and international units; specialist dosing required. | Specialist weight-based dosing only; product units must be checked carefully. |
395. Polymyxin B (Injectable)
Generic name: Polymyxin B sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected severe multidrug-resistant Gram-negative infections | Specialist weight-based loading and maintenance regimen; monitor renal and neurologic toxicity. | Specialist-directed dosing only; do not extrapolate adult regimen. |
396. Fosfomycin Disodium (IV)
Generic name: Fosfomycin disodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected severe infections caused by susceptible bacteria | Dose varies by country, infection, and formulation; specialist-directed IV regimen required. | Weight-based specialist dosing only. |
397. Temocillin
Generic name: Temocillin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected resistant Enterobacterales urinary and bloodstream infections | Follow local product label and infectious-disease guidance; renal adjustment required. | Specialist weight-based dosing; pediatric evidence and approvals vary. |
398. Pivmecillinam
Generic name: Pivmecillinam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Uncomplicated lower urinary tract infection | Use locally approved adult schedule; a commonly used regimen in some countries is 400 mg orally three times daily. | Use only where pediatric approval and a weight-based local regimen are available. |
399. Rifaximin
Generic name: Rifaximin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected noninvasive intestinal infections; hepatic encephalopathy prevention in approved indications | Dose depends on indication and country-specific approval; use the appropriate labeled regimen. | Not established for many indications; pediatric specialist guidance required. |
400. Fidaxomicin
Generic name: Fidaxomicin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Clostridioides difficile infection | 200 mg orally twice daily for 10 days for the standard adult course; recurrence regimens may differ. | Pediatric dosing is age- and weight-specific; use the current approved pediatric label and specialist guidance. |
401. Mupirocin 2% Ointment
Generic name: Mupirocin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Impetigo and localized bacterial skin infection | Apply a thin layer three times daily for up to 10 days. | For eligible children, apply as directed by the product label; age restrictions vary by formulation. |
402. Retapamulin 1% Ointment
Generic name: Retapamulin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Localized impetigo | Apply a thin layer twice daily for 5 days. | For children aged 9 months and older, apply twice daily for 5 days. |
403. Ozenoxacin 1% Cream
Generic name: Ozenoxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Impetigo | Apply a thin layer twice daily for 5 days. | Use in children aged 2 months and older; apply twice daily for 5 days. |
404. Fusidic Acid 2% Cream
Generic name: Fusidic acid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Localized staphylococcal skin infection | Apply a thin layer 2–3 times daily; duration depends on local guidance and product labeling. | Apply according to the product label and clinician’s instructions; age and formulation restrictions apply. |
405. Bacitracin Ointment
Generic name: Bacitracin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Minor superficial skin wounds | Apply a small amount 1–3 times daily as directed by the product label. | Use only as permitted by the product label; avoid unsupervised use in infants. |
406. Neomycin 0.5% Topical Ointment
Generic name: Neomycin sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Minor superficial skin infection prevention | Apply a thin layer 1–3 times daily for short-term use as labeled. | Use only when age-appropriate and directed by a clinician; avoid prolonged or extensive application. |
407. Polymyxin B Topical Ointment
Generic name: Polymyxin B sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Minor superficial wounds involving susceptible bacteria | Apply a thin layer 1–3 times daily according to product labeling. | Follow age-specific product labeling and clinician advice. |
408. Clindamycin 1% Topical Gel
Generic name: Clindamycin phosphate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Inflammatory acne vulgaris | Apply a thin layer once or twice daily, according to formulation. | Use in children only when age-appropriate; combine with benzoyl peroxide when recommended to limit resistance. |
409. Erythromycin 2% Topical Solution
Generic name: Erythromycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acne vulgaris | Apply to affected areas once or twice daily as labeled. | Use only in age groups approved by the specific product label; avoid antibiotic monotherapy when possible. |
410. Dapsone 5% Gel
Generic name: Dapsone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Inflammatory acne vulgaris | Apply a thin layer twice daily, following the product label. | Age-specific approval varies by strength; use only according to the relevant label and clinician advice. |
411. Sulfacetamide Sodium 10% Topical Lotion
Generic name: Sulfacetamide sodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acne and selected superficial bacterial skin conditions | Apply as directed by the product label, commonly once or twice daily. | Pediatric safety and dosing are product-specific; use only under clinician supervision. |
412. Metronidazole 0.75% Topical Gel
Generic name: Metronidazole
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Inflammatory lesions of rosacea | Apply a thin layer once or twice daily, depending on formulation. | Pediatric use is not routinely established; specialist advice required. |
413. Gentamicin 0.1% Topical Cream
Generic name: Gentamicin sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Localized susceptible bacterial skin infection | Apply a thin layer 3–4 times daily as directed by the product label. | Use only for appropriate localized infections under clinician direction; avoid large areas and prolonged treatment. |
414. Silver Sulfadiazine 1% Cream
Generic name: Silver sulfadiazine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Prevention and treatment of infection in selected burns | Apply approximately 1/16-inch layer once or twice daily to cleaned burn areas under burn-care supervision. | Not for premature infants or newborns under 2 months; use in older children only under specialist burn-care guidance. |
415. Mafenide Acetate 8.5% Cream
Generic name: Mafenide acetate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Infection prevention in selected burn wounds | Apply as a thin layer to burn wounds, commonly once or twice daily, under specialist supervision. | Specialist burn-unit dosing only; safety and monitoring requirements are essential. |
416. Ozenoxacin 1% Cream (Second Product Formulation)
Generic name: Ozenoxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Localized impetigo | Use the approved cream formulation twice daily for 5 days. | Use the approved cream formulation in eligible children aged 2 months and older, twice daily for 5 days. |
417. Moxifloxacin 0.5% Eye Drops
Generic name: Moxifloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Instill 1 drop three times daily for 7 days, according to product labeling. | Use the same labeled regimen in eligible children; confirm age approval for the product. |
418. Gatifloxacin 0.3% Eye Drops
Generic name: Gatifloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Instill 1 drop every 2 hours while awake on day 1, then 1 drop 2–4 times daily on days 2–7, according to label. | Follow the age-specific product label; pediatric regimens vary by preparation. |
419. Besifloxacin 0.6% Eye Drops
Generic name: Besifloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Instill 1 drop into the affected eye(s) three times daily for 7 days. | Use the labeled regimen in eligible children; confirm age approval locally. |
420. Levofloxacin 0.5% Eye Drops
Generic name: Levofloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Instill according to the product-specific schedule, commonly every 2 hours initially, then 4 times daily. | Use the age- and formulation-specific labeled schedule. |
421. Ciprofloxacin 0.3% Eye Drops
Generic name: Ciprofloxacin hydrochloride
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Instill 1–2 drops every 2 hours while awake for 2 days, then every 4 hours while awake for 5 days, according to label. | Use the labeled regimen for eligible children; age restrictions vary by product. |
422. Ofloxacin 0.3% Eye Drops
Generic name: Ofloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Instill 1–2 drops every 2–4 hours initially, then reduce frequency as directed by the product label. | Use only according to the age-specific product label and clinician’s instructions. |
423. Tobramycin 0.3% Eye Drops
Generic name: Tobramycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| External bacterial eye infection | Mild/moderate: 1–2 drops every 4 hours; severe infection requires more frequent specialist-directed dosing. | Use the same general labeled approach only when age-appropriate; severe cases require ophthalmology supervision. |
424. Gentamicin 0.3% Eye Drops
Generic name: Gentamicin sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis and superficial ocular infection | Instill 1–2 drops every 4 hours; severe infections may require more frequent dosing under specialist care. | Pediatric dosing must follow the specific ophthalmic product label and ophthalmologist’s instructions. |
425. Erythromycin 0.5% Ophthalmic Ointment
Generic name: Erythromycin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis and superficial eye infection | Apply approximately 1 cm ribbon into the affected eye up to 6 times daily, as directed. | Use the product-specific regimen; newborn prophylaxis is a separate indication and protocol. |
426. Bacitracin Ophthalmic Ointment
Generic name: Bacitracin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Superficial bacterial eye infection | Apply a thin ribbon to the affected eye(s) as directed by the ophthalmic product label. | Use only under clinician direction and according to the age-specific label. |
427. Polymyxin B/Trimethoprim Eye Drops
Generic name: Polymyxin B sulfate and trimethoprim sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Instill 1 drop every 3 hours, up to 6 doses daily, for 7–10 days as labeled. | Use the labeled regimen in eligible children; confirm minimum age for the specific product. |
428. Azithromycin 1% Eye Drops
Generic name: Azithromycin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Instill 1 drop twice daily for 2 days, then once daily for 5 days, according to label. | Use only in eligible children according to the product’s age-specific instructions. |
429. Chloramphenicol 0.5% Eye Drops
Generic name: Chloramphenicol ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Instill 1 drop every 2–6 hours initially, reducing frequency as symptoms improve, according to local guidance. | Use only when approved for the child’s age and under clinician guidance; avoid unsupervised use in newborns. |
430. Chloramphenicol 1% Eye Ointment
Generic name: Chloramphenicol ophthalmic ointment
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Apply a small ribbon inside the lower eyelid 3–4 times daily according to local product labeling. | Follow age-specific product guidance; newborn use requires specialist assessment. |
431. Neomycin/Polymyxin B/Dexamethasone Eye Drops
Generic name: Neomycin, polymyxin B and dexamethasone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected steroid-responsive ocular inflammation with bacterial infection or risk | Instill 1–2 drops up to 4–6 times daily only when prescribed by an ophthalmologist. | Specialist-only use; steroid-containing eye drops can worsen certain infections and raise intraocular pressure. |
432. Tobramycin/Dexamethasone Eye Drops
Generic name: Tobramycin and dexamethasone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Steroid-responsive ocular inflammation with bacterial infection or risk | Instill 1–2 drops every 4–6 hours initially, only under ophthalmologist supervision. | Use only when specifically prescribed by an ophthalmologist; age and monitoring requirements apply. |
433. Ciprofloxacin 0.3% Ophthalmic Ointment
Generic name: Ciprofloxacin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Apply a 1.25 cm ribbon into the affected eye(s) three times daily for 2 days, then twice daily for 5 days, according to label. | Use the same labeled regimen only in children for whom the product is approved. |
434. Ofloxacin 0.3% Ophthalmic Ointment
Generic name: Ofloxacin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial ocular infection | Use the ophthalmic ointment only according to the specific product’s dosing instructions. | Pediatric use and dosing depend on local approval and specialist advice. |
435. Ciprofloxacin 0.2% Ear Drops
Generic name: Ciprofloxacin otic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute otitis externa | Use the product-specific number of drops twice daily for the labeled course. | Use the age-specific labeled regimen; avoid unapproved products when tympanic membrane perforation is possible. |
436. Ciprofloxacin 0.3% Ear Drops
Generic name: Ciprofloxacin otic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Otitis externa | Instill the labeled number of drops twice daily, generally for 7 days, depending on formulation. | Follow the product’s approved age range and dosing instructions. |
437. Ofloxacin 0.3% Ear Drops
Generic name: Ofloxacin otic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Otitis externa and selected middle-ear infections | Otitis externa: commonly 10 drops once daily for 7 days; other indications have different regimens. | Dose depends on age and indication; use the exact approved product label. |
438. Ciprofloxacin/Dexamethasone Ear Drops
Generic name: Ciprofloxacin and dexamethasone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute otitis externa and acute otitis media with tympanostomy tubes | Instill 4 drops twice daily for 7 days, according to label. | For eligible children, 4 drops twice daily for 7 days; verify minimum age and indication. |
439. Neomycin/Polymyxin B/Hydrocortisone Ear Drops
Generic name: Neomycin, polymyxin B and hydrocortisone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial otitis externa | Instill 4 drops into the affected ear 3–4 times daily as labeled. | Use only when the tympanic membrane is intact and the product is age-approved; clinician-directed dosing. |
440. Gentamicin 0.3% Ear Drops
Generic name: Gentamicin otic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected bacterial ear infections | Use only according to local product labeling and ENT guidance. | Specialist-directed dosing only; aminoglycoside ear drops may cause ototoxicity when the tympanic membrane is perforated. |
441. Clindamycin 2% Vaginal Cream
Generic name: Clindamycin phosphate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial vaginosis | Insert one applicatorful intravaginally at bedtime for 3 or 7 days, depending on formulation. | Not routinely established for prepubertal children; specialist assessment required. |
442. Clindamycin 100 mg Vaginal Ovules
Generic name: Clindamycin phosphate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial vaginosis | Insert one ovule intravaginally at bedtime for 3 consecutive nights, according to label. | Pediatric use is not routinely established; specialist advice required. |
443. Metronidazole 0.75% Vaginal Gel
Generic name: Metronidazole
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial vaginosis | Insert one 5 g applicator intravaginally once daily for 5 days, or follow the specific product label. | Not routinely established for children; specialist assessment required. |
444. Metronidazole 1.3% Vaginal Gel
Generic name: Metronidazole
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial vaginosis | Insert one applicatorful intravaginally as a single dose, according to product labeling. | Not established for routine pediatric use. |
445. Metronidazole 500 mg Vaginal Tablets
Generic name: Metronidazole
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial vaginosis, where this formulation is locally approved | Use the locally approved intravaginal regimen; formulations and schedules vary by country. | Not routinely established; specialist advice required. |
446. Clindamycin 1% Vaginal Gel
Generic name: Clindamycin phosphate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial vaginosis, where formulation is approved | Use the product-specific intravaginal regimen; do not substitute the 2% cream schedule. | Not routinely established for children. |
447. Cefiderocol
Generic name: Cefiderocol
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated urinary tract infection and selected infections caused by resistant Gram-negative bacteria | 2 g IV every 8 hours infused over 3 hours when renal function is normal; adjust for renal function. | Safety and efficacy are not established for routine pediatric use; infectious-disease specialist required. |
448. Sulbactam/Durlobactam
Generic name: Sulbactam and durlobactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Hospital-acquired and ventilator-associated bacterial pneumonia caused by susceptible Acinetobacter baumannii-calcoaceticus complex | 1 g/1 g IV every 6 hours over 3 hours, with imipenem/cilastatin; adjust for renal function. | Pediatric dosing is not established; specialist-only use. |
449. Ceftolozane/Tazobactam
Generic name: Ceftolozane and tazobactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated intra-abdominal infection, complicated urinary infection and hospital-acquired pneumonia | 1.5 g IV every 8 hours for cIAI/cUTI; 3 g IV every 8 hours for HABP/VABP. Adjust for renal function. | For approved pediatric indications, use weight-based dosing from the current label; maximum dose and renal function must be checked. |
450. Ceftazidime/Avibactam
Generic name: Ceftazidime and avibactam
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated urinary infection, intra-abdominal infection and selected resistant Gram-negative infections | 2.5 g IV every 8 hours infused over 2 hours when renal function is normal; adjust for renal function. | Weight-based pediatric dosing is approved for selected ages and indications; verify current label and renal function. |
451. Ceftaroline Fosamil
Generic name: Ceftaroline fosamil
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute bacterial skin and skin-structure infection and community-acquired bacterial pneumonia | 600 mg IV every 12 hours; adjust for renal impairment and indication. | Age- and weight-based dosing is available for selected pediatric ages; use current product labeling. |
452. Eravacycline
Generic name: Eravacycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated intra-abdominal infection | 1 mg/kg IV every 12 hours; usual course depends on clinical response and infection. | Pediatric safety and efficacy are not established; avoid routine use in children. |
453. Omadacycline
Generic name: Omadacycline
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Community-acquired bacterial pneumonia and acute bacterial skin infection | Oral: 450 mg daily for 2 days, then 300 mg daily; IV: 100 mg every 12 hours on day 1, then 100 mg daily. | Pediatric use is not established; specialist advice required. |
454. Lefamulin
Generic name: Lefamulin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Community-acquired bacterial pneumonia | 150 mg IV every 12 hours or 600 mg orally every 12 hours for 5–7 days, as labeled. | Pediatric safety and efficacy are not established. |
455. Delafloxacin
Generic name: Delafloxacin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute bacterial skin infection and community-acquired bacterial pneumonia | 300 mg IV every 12 hours or 450 mg orally every 12 hours; duration depends on indication. | Pediatric use is not established; avoid routine use. |
456. Plazomicin
Generic name: Plazomicin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated urinary tract infection caused by susceptible organisms | 15 mg/kg IV every 24 hours; adjust based on renal function and drug-level monitoring. | Pediatric safety and efficacy are not established. |
457. Dalbavancin
Generic name: Dalbavancin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute bacterial skin and skin-structure infection | 1,500 mg IV once, or 1,000 mg IV followed by 500 mg IV one week later; adjust in selected renal impairment. | Pediatric dosing is weight- and age-dependent; use current approved labeling and specialist guidance. |
458. Oritavancin
Generic name: Oritavancin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute bacterial skin and skin-structure infection | 1,200 mg IV once, infused over 3 hours. | Pediatric safety and efficacy are not established. |
459. Telavancin
Generic name: Telavancin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Complicated skin infection and selected hospital-acquired pneumonia | 10 mg/kg IV every 24 hours, infused over approximately 60 minutes; adjust for renal function. | Pediatric safety and efficacy are not established. |
460. Tedizolid
Generic name: Tedizolid phosphate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acute bacterial skin and skin-structure infection | 200 mg orally or IV once daily for 6 days. | Age- and weight-based dosing is available for selected pediatric patients; follow current label. |
461. Colistimethate Sodium
Generic name: Colistimethate sodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Severe infections caused by susceptible multidrug-resistant Gram-negative bacteria | Dose must be calculated in international units or colistin base activity using renal function and local specialist protocol; units are not interchangeable. | Specialist-only weight- and renal-function-based dosing; verify the exact product units. |
462. Polymyxin B Injection
Generic name: Polymyxin B sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Severe multidrug-resistant Gram-negative infection | Specialist dosing based on body weight, infection site and toxicity monitoring; not suitable for unsupervised standard dosing. | Pediatric infectious-disease specialist dosing only. |
463. Fosfomycin Intravenous
Generic name: Fosfomycin disodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected severe infections caused by susceptible bacteria | IV dose varies widely by infection, renal function and national product label; specialist-guided dosing is required. | Age- and weight-specific specialist dosing only; confirm local approval. |
464. Fosfomycin Tromethamine Oral Sachet
Generic name: Fosfomycin tromethamine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Uncomplicated acute cystitis in women | 3 g orally as a single dose, dissolved in water, according to label. | Not routinely recommended for children unless specifically directed by a specialist and supported by local guidance. |
465. Nitrofurantoin Oral Suspension
Generic name: Nitrofurantoin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Uncomplicated lower urinary tract infection | Dose depends on formulation; use the specific immediate-release or modified-release product schedule. | Weight-based dosing depends on age and formulation; avoid in infants under 1 month and check renal function. |
466. Methenamine Hippurate
Generic name: Methenamine hippurate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Prevention of recurrent urinary tract infection | 1 g orally twice daily for prevention when appropriate; not a treatment for acute systemic UTI. | Pediatric use requires specialist assessment; dose depends on age and product labeling. |
467. Nitrofurazone 0.2% Ointment
Generic name: Nitrofurazone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected infected wounds and burns | Apply according to the wound-care product label and specialist protocol. | Pediatric safety and dosing depend on product approval; use only under specialist supervision. |
468. Bacitracin/Neomycin/Polymyxin B Ointment
Generic name: Bacitracin, neomycin and polymyxin B
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Minor superficial skin wounds | Apply a small amount 1–3 times daily according to product labeling. | Use only for age-approved minor wounds; avoid large areas and prolonged use. |
469. Bacitracin/Polymyxin B Ophthalmic Ointment
Generic name: Bacitracin and polymyxin B
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Superficial bacterial ocular infection | Apply a thin ribbon to the affected eye(s) according to ophthalmic product labeling. | Use only under clinician direction and according to age-specific product labeling. |
470. Sulfacetamide 10% Ophthalmic Drops
Generic name: Sulfacetamide sodium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Instill 1–2 drops every 2–3 hours initially, reducing frequency as infection improves, according to label. | Use only if approved for the child’s age; avoid in infants unless specifically directed. |
471. Clindamycin 1% Topical Lotion
Generic name: Clindamycin phosphate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acne vulgaris | Apply a thin layer once or twice daily according to formulation. | Use only in age-approved children; avoid antibiotic monotherapy when possible. |
472. Clindamycin 1% Topical Solution
Generic name: Clindamycin phosphate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acne vulgaris | Apply to affected areas once or twice daily according to the product label. | Use only when approved for the child’s age; combine with a non-antibiotic acne treatment when recommended. |
473. Erythromycin 2% Topical Gel
Generic name: Erythromycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acne vulgaris | Apply a thin layer once or twice daily according to product labeling. | Pediatric use depends on product approval and age; avoid unnecessary prolonged antibiotic use. |
474. Erythromycin 2% Topical Lotion
Generic name: Erythromycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Acne vulgaris | Apply a thin layer once or twice daily, as directed by the specific formulation. | Use only in age-approved children and according to clinician instructions. |
475. Metronidazole 1% Topical Gel
Generic name: Metronidazole
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Rosacea-associated inflammatory lesions | Apply a thin layer once daily or according to the product label. | Routine pediatric use is not established; specialist advice required. |
476. Mupirocin 2% Nasal Ointment
Generic name: Mupirocin calcium
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) | Apply a small amount inside each nostril twice daily for 5 days when prescribed for decolonization. | Use only when age-approved and prescribed under a decolonization protocol. |
477. Mupirocin 2% Cream
Generic name: Mupirocin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Secondarily infected traumatic skin lesions | Apply a thin layer three times daily for up to 10 days, according to label. | Use only in age-approved children; check the formulation’s minimum age. |
478. Retapamulin 1% Ointment (Pediatric Formulation)
Generic name: Retapamulin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Impetigo | Apply twice daily for 5 days. | For children aged 9 months and older, apply twice daily for 5 days. |
479. Fusidic Acid 2% Ointment
Generic name: Fusidic acid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Localized susceptible staphylococcal skin infection | Apply a thin layer 2–3 times daily for the locally recommended duration. | Use according to age-specific product instructions; avoid prolonged or repeated courses. |
480. Fusidic Acid 2% Ophthalmic Preparation
Generic name: Fusidic acid ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis caused by susceptible organisms | Use the ophthalmic formulation at the labeled frequency, commonly twice daily for the prescribed course. | Use only if approved for the child’s age and under clinician guidance. |
481. Povidone-Iodine 5% Ophthalmic Solution
Generic name: Povidone-iodine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Ocular surface antisepsis before ophthalmic procedures | Applied by ophthalmic professionals as a single procedural antiseptic preparation; not a routine home eye drop. | Professional procedural use only; pediatric concentration and exposure must follow ophthalmic protocol. |
482. Povidone-Iodine 10% Topical Solution
Generic name: Povidone-iodine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Skin antisepsis before procedures and selected wound care | Apply to the skin according to the antiseptic product label; allow appropriate contact and drying time. | Use only in age-appropriate patients; avoid extensive or repeated application in neonates unless specifically directed. |
483. Chlorhexidine 2% Skin Preparation
Generic name: Chlorhexidine gluconate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Pre-procedure skin antisepsis | Apply using the product’s preparation technique and allow to dry fully; not a systemic antibiotic. | Age restrictions and concentration are product-specific; avoid contact with eyes, ears and mucous membranes. |
484. Chlorhexidine 4% Skin Wash
Generic name: Chlorhexidine gluconate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Skin cleansing and selected decolonization protocols | Use as a skin wash according to the prescribed decolonization or antisepsis protocol. | Do not use routinely in infants; age-specific concentration and protocol must be confirmed. |
485. Triclosan 1% Antibacterial Preparation
Generic name: Triclosan
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Antiseptic skin cleansing where an approved product is available | Use only according to the specific antiseptic product instructions; not a treatment for established invasive infection. | Pediatric use depends on the product and local regulations; no universal dose. |
486. Hydrogen Peroxide 3% Topical Solution
Generic name: Hydrogen peroxide
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected short-term cleansing of minor superficial wounds | If used, follow product directions for brief cleansing only; routine use on wounds is generally discouraged because it can damage tissue. | Not recommended for routine wound treatment in children; use safer wound-cleaning methods. |
487. Acetic Acid 2% Otic Solution
Generic name: Acetic acid
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected uncomplicated otitis externa | Instill the labeled number of drops 3–4 times daily when prescribed. | Use only under clinician guidance; avoid if tympanic membrane perforation is suspected. |
488. Acetic Acid/Hydrocortisone Otic Drops
Generic name: Acetic acid and hydrocortisone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Inflammatory otitis externa with susceptible superficial organisms | Instill the labeled number of drops 3–4 times daily for the prescribed course. | Use only if age-approved and tympanic membrane status is suitable; clinician assessment required. |
489. Polymyxin B/Neomycin/Hydrocortisone Otic Suspension
Generic name: Polymyxin B, neomycin and hydrocortisone
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Otitis externa | Instill the labeled number of drops 3–4 times daily for the prescribed duration. | Only for age-approved children with an intact tympanic membrane; follow clinician instructions. |
490. Bacitracin Zinc Topical Ointment
Generic name: Bacitracin zinc
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Minor superficial skin wounds | Apply a small amount 1–3 times daily as directed by the product label. | Use only on limited areas when age-appropriate; avoid prolonged application and allergic reactions. |
491. Neomycin/Polymyxin B/Bacitracin Ophthalmic Ointment
Generic name: Neomycin, polymyxin B and bacitracin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Superficial bacterial eye infection | Apply a thin ribbon to the affected eye(s) according to the ophthalmic product label. | Use only under clinician direction and according to age-specific labeling. |
492. Sulfadiazine Silver 1% Cream (Burn-care Product)
Generic name: Silver sulfadiazine
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Burn wound infection prevention and treatment | Apply approximately 1/16-inch layer once or twice daily to cleaned burn areas under burn-care supervision. | Avoid in premature infants and newborns under 2 months; older children require specialist guidance. |
493. Mafenide Acetate 5% Solution
Generic name: Mafenide acetate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected burn wound infection management | Apply using the prescribed dressing and solution protocol; frequency is determined by the burn-care team. | Specialist burn-unit protocol only; monitor for metabolic complications. |
494. Gentian Violet 1% Topical Solution
Generic name: Gentian violet
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Selected superficial skin or mucosal infections where locally approved | Use only according to a locally approved product label; availability and recommendations vary. | Not recommended for routine pediatric use without specialist advice. |
495. Sodium Fusidate 2% Cream
Generic name: Sodium fusidate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Localized susceptible staphylococcal skin infection | Apply a thin layer 2–3 times daily according to local product labeling. | Use the age-appropriate product regimen; avoid repeated or prolonged courses. |
496. Sodium Fusidate 2% Ointment
Generic name: Sodium fusidate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Localized bacterial skin infection | Apply a thin layer 2–3 times daily for the locally recommended duration. | Follow age-specific labeling and clinician guidance. |
497. Bacitracin/Neomycin Topical Cream
Generic name: Bacitracin and neomycin
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Minor superficial wounds at risk of localized bacterial contamination | Apply a thin layer according to the specific combination product label. | Use only on small areas when approved for age; avoid prolonged use and sensitization. |
498. Neomycin/Polymyxin B Topical Ointment
Generic name: Neomycin and polymyxin B
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Minor superficial wounds | Apply a thin layer 1–3 times daily according to product labeling. | Use only for limited superficial wounds and according to age-specific labeling. |
499. Polymyxin B/Trimethoprim Ophthalmic Solution (Alternative Brand Formulation)
Generic name: Polymyxin B sulfate and trimethoprim sulfate
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| Bacterial conjunctivitis | Instill 1 drop every 3 hours, up to 6 doses daily, for 7–10 days as labeled. | Use only in eligible children according to the exact product label. |
500. Tobramycin 0.3% Ophthalmic Ointment
Generic name: Tobramycin ophthalmic
| Infection Category | Adult Dosage | Pediatric Dosage |
|---|---|---|
| External bacterial eye infection | Apply a small ribbon into the affected eye(s) 2–3 times daily; severe infection requires ophthalmologist-directed treatment. | Use only when age-appropriate and prescribed by an eye-care professional. |
“`